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Riassunto 
La malattia di Alzheimer (AD, Alzheimer’s disease) è la malattia neurodegenerativa più 
diffusa, colpendo più di 35 milioni di persone a livello mondiale. Nonostante la maggior 
parte dei casi sia dovuta ad una combinazione di fattori di rischio (genetici e ambientali), 
una piccola percentuale è ereditata geneticamente ed è perciò chiamata forma familiare di 
AD (FAD). Questa forma di Alzheimer è causata da mutazioni in tre geni: APP, che 
codifica per la proteina precursore dell’amiloide, e nei geni PSEN1 e PSEN2, codificanti 
rispettivamente per la presenilina 1 e 2 (PS1, PS2). Mutazioni in questi geni inducono un 
aumento nella formazione del prodotto del taglio di APP, il peptide β amiloide (Aβ): nella 
malattia i livelli di Aβ42, la forma di 42 amminoacidi del peptide Aβ più prona ad 
aggregare, sono aumentati portando alla formazione delle placche amiloidi che si ritrovano 
numerose nel cervello dei pazienti. Secondo “l’ipotesi amiloide” l’accumulo di Aβ innesca 
una cascata di eventi che porta ad una progressiva disfunzione a livello delle sinapsi e dei 
neuroni ed infine alla morte cellulare.   
In questo scenario, le preseniline svolgono un ruolo importante. Le preseniline sono 
proteine di membrana ben conosciute come componenti della γ-secretasi, un complesso 
enzimatico localizzato a livello della membrana plasmatica e delle membrane interne 
(Golgi e reticolo endoplasmatico, RE) responsabile del taglio di diverse proteine, tra cui 
NOTCH e APP. Tuttavia le preseniline svolgono anche funzioni indipendenti dalla γ-
secretasi: in particolare è stato descritto recentemente che PS2, ma non PS1, è in grado di 
modulare la vicinanza tra RE e mitocondri, e lo scambio di Ca2+ tra questi due organelli. 
La sovra-espressione di mutazioni in PSEN2 associate a FAD aumenta sia la vicinanza 
fisica che il trasferimento di Ca2+ tra questi due organelli. Alterazioni nell’omeostasi 
intracellulare del Ca2+ sono comunemente riportate in diversi modelli sperimentali della 
patologia di Alzheimer e ciò ha fatto emergere un’ipotesi patogenetica aggiuntiva in cui 
tali fenomeni svolgono un ruolo chiave: molti processi cellulari, infatti, dipendono da un 
adeguato signalling intracellulare del Ca2+ e ci si aspetta che eventuali disfunzioni abbiano 
conseguenze sulla fisiologia del neurone. Tra i processi cellulari mediati dal Ca2+, il 
trasporto dei mitocondri lungo gli assoni rappresenta un punto fondamentale: i mitocondri 
sono organelli essenziali per la cellula, capaci di modulare, con la loro funzionalità, diversi 
aspetti della fisiologia della cellula. Il trasporto assonale dei mitocondri è finemente 
regolato dal Ca2+: aumenti nei livelli citosolici di Ca2+ interrompono il trasporto dei 
mitocondri lungo gli assoni, al fine di localizzarli in siti opportuni ad elevata attività 
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metabolica (ad es. in sinapsi attive). Le alterazioni nell’omeostasi intracellulare del Ca2+ 
così come l’aumentata vicinanza tra RE e mitocondri, dovuti all’espressione di mutazioni 
in PSEN2 associate a FAD, potrebbero quindi modificare il trasporto assonale dei 
mitocondri, e determinare alterazioni nella distribuzione dei mitocondri a livello neuronale, 
caratteristica riscontrata in diversi modelli di AD.   
Zebrafish si è dimostrato un modello animale molto attraente per studiare diverse malattie 
umane: in particolare, il suo genoma è ampiamente annotato e gli ortologhi dei geni 
coinvolti nelle forme familiari di AD sono già stati identificati. L’analisi del trasporto 
assonale dei mitocondri è facilitata dalla trasparenza degli embrioni e dalla disponibilità di 
strumenti che consentono di manipolare in maniera semplice l’espressione dei geni 
d’interesse.   
Nel lavoro qui presentato abbiamo generato una metodica che consente lo studio in vivo 
delle dinamiche assonali mitocondriali dipendenti dalla presenilina 2.  
Per prima cosa, attraverso l’espressione della proteina fluorescente Kaede indirizzata ai 
mitocondri dei neuroni sensitivi Rohon-Beard (RB), abbiamo caratterizzato le proprietà del 
trasporto assonale dei mitocondri nel corso dello sviluppo: la percentuale di mitocondri 
mobili si riduce passando da embrioni di un giorno a quelli di tre; tuttavia la velocità media 
del loro trasporto aumenta nel corso dello sviluppo. La direzionalità del trasporto assonale 
dei mitocondri è fortemente sbilanciata verso il trasporto anterogrado, rispecchiando una 
traslocazione netta di mitocondri dal corpo cellulare alle ramificazioni assonali terminali. Il 
trattamento con nocodazolo, un forte inibitore della polimerizzazione dei microtubuli, 
altera completamente il trasporto assonale dei mitocondri, validando così la sensibilità del 
nostro metodo di analisi. Le caratteristiche del trasporto mitocondriale misurate con il 
nostro approccio, inoltre, sono simili a quelle riportate in altri studi in vivo recentemente 
pubblicati. 
Successivamente, abbiamo verificato la presenza di eventuali effetti sul trasporto indotti 
dall’espressione di presenilina 2: abbiamo dimostrato come il knockdown di psen2, ma non 
di psen1, riduce la percentuale di mitocondri mobili. Questo fenotipo è ripristinato da 
esperimenti di rescue, in cui viene re-introdotto il gene per la presenilina 2, dimostrando un 
effetto specifico della proteina. 
L’espressione della PS2 umana in zebrafish ha portato a risultati diversi: la proteina umana 
(sia wild-type, wt, che mutata) si esprime nelle membrane interne a livello del corpo 
cellulare e lungo l’assone dei neuroni RB, dove si localizza principalmente a livello del 
RE. Mentre però la sovra-espressione della PS2 wt non ha alcun effetto sul trasporto 
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assonale dei mitocondri, la forma mutata PS2-T122R aumenta la percentuale di mitocondri 
mobili.  
Abbiamo inoltre verificato se aumenti di Ca2+ a livello della matrice mitocondriale, indotti 
da un aumento del Ca2+ a livello citosolico, potessero funzionare da segnale coinvolto nella 
regolazione del trasporto mitocondriale, come recentemente proposto: il knockdown della 
proteina principale dell’uniporto mitocondriale del calcio (Mcu, Mitochondrial calcium 
uniporter), tuttavia, non ha nessun effetto sia sulla percentuale di mitocondri mobili che 
sulla loro velocità media. 
Dato che cambiamenti nella forma dei mitocondri possono influenzarne velocità e 
trasporto abbiamo analizzato anche la morfologia e la densità dei mitocondri lungo gli 
assoni dei neuroni RB dopo espressione di PS2 umana: entrambi i parametri tuttavia sono 
risultati invariati nelle varie condizioni analizzate, suggerendo che le alterazioni osservate 
nel trasporto mitocondriale indotte dalla PS2 non siano dovute né ad uno squilibrio nella 
fusione/fissione né ad una alterata biogenesi dei mitocondri.  
Ulteriori studi saranno necessari per comprendere il meccanismo che modula l’alterato 
trasporto mitocondriale qui descritto, così come il peso di queste alterazioni nella 
patogenesi dell’Alzheimer. 
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Abstract 
Alzheimer’s disease (AD) is the most common form of neurodegenerative disease, 
affecting more than 35 million people worldwide. Although the majority of cases is caused 
by a combination of risk factors (genetic and environmental), a small percentage is 
genetically inherited and is called familial Alzheimer’s disease (FAD). FAD is caused by 
mutations in three genes: APP, which encodes for the amyloid precursor protein, and 
presenilins genes (PSEN1 and PSEN2), encoding for presenilin 1 and 2 (PS1, PS2), 
respectively. Mutations in these genes result in an increased formation of the product of 
APP cleavage, the amyloid Aβ peptide: in AD the levels of Aβ42, the most aggregation-
prone, 42 amino acids long, form of Aβ, are increased, leading to the formation of amyloid 
plaques in patients’ brains. According to the “amyloid hypothesis”, Aβ accumulation 
triggers a cascade that leads to progressive synaptic and neuronal injury and eventually to 
cell death.  
In this scenario, presenilins play a key role. Presenilins are membrane spanning proteins 
known to most as key components of the γ-secretase, the enzymatic complex located in 
plasma membrane and internal membranes (Golgi and endoplasmic reticulum, ER) 
responsible for the cleavage of many proteins, including NOTCH and APP. However, they 
also have γ-secretase-independent functions: in particular PS2, but not PS1, has been 
recently described to be able to modulate ER-mitochondria tethering and their Ca2+ cross-
talk. The overexpression of FAD-linked PS2 mutants increases both the tethering and the 
Ca2+ transfer between these two organelles. It’s worth mentioning that alterations in Ca2+ 
signalling are emerging as an attractive hypothesis to explain AD pathogenesis: many 
cellular processes are dependent on a proper Ca2+ signalling, and any dysfunction is 
expected to have consequences on neuronal physiology. Among these processes, 
mitochondrial axonal transport represents a very interesting feature: mitochondria are key 
organelles for cells, whose functions influence several cell life aspects as well as cell death. 
Mitochondrial axonal transport is finely regulated by Ca2+: increases in cytosolic Ca2+ 
levels arrest mitochondrial movements along axons, to ensure their deliver to metabolically 
active sites, such as activated synapses. The previously described FAD-PS2 mediated 
alterations in Ca2+ handling and in the physical interaction between ER and mitochondria 
could potentially modify axonal mitochondrial transport, and an altered mitochondrial 
distribution has been reported within neuronal cells in different AD models.  
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Zebrafish has emerged as an attractive vertebrate system to study human diseases: in 
particular, its genome is extensively annotated and orthologs of genes involved in FAD 
have been already identified. Mitochondrial axonal transport analysis is strongly facilitated 
by the transparency of embryos and by the availability of tools to manipulate gene 
expression.  
We here generated a method to study PS2-dependent effects on mitochondrial dynamics in 
vivo. Firstly, by genetically targeting the fluorescent protein Kaede to mitochondria in 
Rohon-Beard (RB) sensory neurons, we have characterized mitochondrial axonal transport 
properties during development. We found that the percentage of mobile mitochondria is 
reduced from one to three days post fertilization (dpf) embryos; mitochondrial average 
speed, however, increases during development. The directionality of transport is strongly 
biased towards the anterograde one, reflecting a net translocation of mitochondria from the 
cell body to peripheral arbors. Nocodazole, a strong inhibitor of microtubule 
polymerization, totally disrupts mitochondrial axonal transport, validating the sensitivity of 
our assay. Interestingly, the mitochondrial axonal transport parameters, measured with our 
approach, are similar to those reported in recent in vivo studies. 
We found that psen2 knockdown (KD), but not psen1 KD, reduces the percentage of 
motile organelles, compared to controls. This phenotype is recovered by rescue 
experiments, in which PS2 was re-introduced, demonstrating a specific PS2-dependent 
effect. 
On the other side, human PS2 expression in zebrafish leads to different results: human PS2 
(both wild-type, wt, and mutated) is expressed at the level of intracellular membranes  
(mainly in the ER) in the soma and through the axon of RB neurons but, while 
overexpression of wt PS2 does not affect mitochondrial axonal transport, that of the PS2-
T122R mutant increases the percentage of motile mitochondria.  
Moreover, we verified whether intra-mitochondrial Ca2+ rises could be involved as signal 
in the regulation of mitochondrial axonal transport, as previously proposed: the KD of the 
mitochondrial calcium uniporter (Mcu), the protein responsible for mitochondrial Ca2+ 
uptake, however, is without effect on either the speed and the percentage of motile 
mitochondria in RB neurons. 
Mitochondrial morphology and density were also investigated and both features resulted 
unchanged upon the different treatments, suggesting that the observed alterations in 
mitochondrial axonal transport induced by PS2 are due to neither an imbalance in 
mitochondrial fusion and fission nor an abnormal mitochondrial biogenesis.  
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Further investigations are required to better understand the mechanism through which PS2 
alters mitochondrial axonal transport, as well as the role played by this alteration in AD 
pathogenesis. 
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1 Introduction 
1.1 The axonal transport   
Neurons are highly polarized cells that can be divided in three distinct domains: the cell 
body (soma), the axon and dendrites, each playing different roles in neuron function and 
owing different sets of molecular machinery. The synthesis and biogenesis of the major 
cellular components  (proteins, lysosomes, ER membranes, synaptic vesicles etc.) occur in 
the cell body: to deliver newly synthesized molecules to synapses, a conserved mechanism 
evolved based on anterograde axonal transport (Fig. 1-1). When these materials are 
delivered to the proper place, they exert their function and age, accumulating oxidative 
damage that compromises their function.  
To ensure neuronal functions, these materials are transported back to the cell body by 
retrograde transport. Both transports (anterograde and retrograde) use microtubule tracks to 
deliver materials to the proper sites. Because axonal microtubules are polarized in the 
axon, with their plus end pointing towards the axon terminal, anterograde transport refers 
to translocation of materials from the soma to peripheral axons, using kinesin motors, 
whereas retrograde transport reflects translocations towards the cell body using dynein 
motors. 
Axonal transport is commonly divided in two categories: fast axonal transport, which 
drives the movement of membrane-bound organelles, and slow axonal transport, which is 
referred to the movement of cytoplasmic and cytoskeletal proteins (Millecamps and Julien, 
2013). The cargoes transported along microtubules in axon include a variety of proteins 
(tubulin, actin, tau, enzymes, membrane proteins), mRNAs and membrane-bound 
organelles, such as Golgi-derived vesicles, lysosomes, autophagosomes and mitochondria. 
These cargoes move in a saltatory way, alternating periods of movement with pauses and 
directional switches, and they differ for the average speed and directionality of movements.  
Among all the cargoes transported in axons, mitochondria represent an important fraction: 
neurons are strongly dependent on mitochondrial functionality, due to their high metabolic 
demand, Ca2+ handling requirements and susceptibility to ROS damage. Different areas of 
the cell (soma, dendrites and synapses) have distinct energetic and metabolic needs, and 
mitochondrial distribution has the purpose of satisfying them: mitochondria accumulate 
more in area with high ATP and Ca2+ buffering requirements (like synaptic terminals, 
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active growth cone, nodes of Ranvier or axonal branches) (Fabricius et al., 1993; Li et al., 
2004; Ruthel and Hollenbeck, 2003).  
Thus, mitochondrial axonal transport evolved to ensure the proper distribution and 
positioning of mitochondria inside the cell. 
 
 
Figure 1-1. Axonal transport of cargoes. Schematic representation of a peripheral neuron showing the somato-dendritic 
region (cell body) and the axon. To ensure neuronal survival and functions, vesicles (yellow), mitochondria (red) and 
endocytic organelles (orange) are transported from the cell body to synapses (anterogradely) or back to the soma 
(retrogradely). Both kinds of transport use motor proteins to drive cargoes transport along microtubules (green). From 
(Saxton and Hollenbeck, 2012).   
 
1.2 The mitochondrial axonal transport machinery  
Long-range mitochondrial transport is achieved exploiting microtubule tracks. A growing 
number of proteins has been identified to be involved in mitochondrial axonal transport. 
The main components of the mitochondrial transport machinery are listed below (Fig. 1-2): 
• motor proteins: these proteins drive mitochondrial transport through ATP 
hydrolysis. The main motors are kinesin for anterograde transport and dynein for 
the retrograde one. Among all kinesins, members of the kinesin-1 family (KIF5) 
play a major role in the anterograde transport of mitochondria (Pilling et al., 2006; 
Tanaka et al., 1998). Kinesin-1 is a tetramer composed of two kinesin heavy chains 
(KHCs) and two kinesin light chains (KLCs). Each KHC contains the motor 
domain that binds to ATP and microtubule, a neck linker, a stalk involved in 
dimerization and a tail, that mediates kinesin linkage to cargoes through KLCs 
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(Hirokawa et al., 2010). Three KIF5 isoforms have been found in mammals 
(KIF5A, KIF5B, KIF5C): KIF5A and KIF5C are found only in neurons, where they 
associate with many cargoes, including mitochondria (Hirokawa et al., 1991).  
Retrograde transport is performed by cytoplasmic dynein (Pilling et al., 2006). 
Dynein is a multisubunit complex composed of two heavy chains, two intermediate 
chains, four light intermediate chains and several light chains (Eschbach and 
Dupuis, 2011). Dynein heavy chains are the catalytic domains with ATPase 
activity: they bind to microtubules and to intermediate and light chains, thus 
driving mitochondrial transport. Although it is established that dynein heavy chains 
function as motor, the link between dynein and mitochondria is still unknown.  
The rapid directional switch of mitochondrial movements suggests that all motor 
proteins are bound to mitochondria and finely regulated to obtain a net straight 
movement. Alternatively, mitochondria can change their affinities for different 
motors, the directionality of movements being determined by the motor with 
highest affinity.  
• motor adaptors: to guarantee cargo-specific transport regulation, adaptor proteins 
link mitochondria to motors. In Drosophila the Miro-Milton complex achieves this 
purpose for the anterograde transport. Miro is a mitochondrial outer membrane 
protein belonging to the Rho family of GTP hydrolases (Fransson et al., 2003, 
2006). It contains two GTPase and two EF-hand Ca2+ binding domains and it is 
involved in the Ca2+-mediated regulation of mitochondrial transport. Milton is the 
adaptor that physically links mitochondria to motors, by binding to Miro and to the 
C-terminal cargo-binding domain of KHC (Glater et al., 2006; Stowers et al., 
2002).  In mammals two Milton orthologues (TRAK1 and TRAK2) and two Miro 
orthologues (MIRO1 and MIRO2) have been identified, and MIRO1 has been 
shown to interact with TRAK2 and regulate mitochondrial axonal transport in 
hippocampal neurons (MacAskill et al., 2009). In addition to Milton, syntabulin is 
another kinesin adaptor protein for mitochondria (Cai et al., 2005): it binds to the 
cargo-binding domain of kinesin and to mitochondria through its C-terminal 
domain. Concerning dynein, several proteins have been hypothesized to function as 
adaptors, but they are less characterized than those required for anterograde 
transport. However it still remains unclear whether dynein links mitochondria 
directly through its light and intermediate chains or through other proteins. Among 
them, dynactin, a large 11-subunit complex, has been reported to bind dynein, to 
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associate with mitochondria and to be essential for retrograde mitochondrial 
transport (Pilling et al., 2006). The dynactin complex contains many polypeptides 
and is composed by a rod domain involved in cargo binding and an arm responsible 
for the binding of microtubules. Genetic silencing of dynactin in Drosophila leads 
to an alteration of the axonal transport of mitochondria and to axon degeneration 
(Martin et al., 1999).  
• static anchor: syntaphilin is a neuron specific, axonal targeted protein that binds to 
the mitochondrial outer membrane through its C-terminal domain. It functions as an 
anchor that docks mitochondria to sites of high metabolic and Ca2+-buffering 
demands (Kang et al., 2008). The presence of serine residues and phosphorylation 
sites suggests that this docking function may be modulated by different signals. 
Syntaphilin knockout (KO) dramatically increases the percentage of motile 
mitochondria in the axon, whereas its overexpression abolishes axonal 
mitochondrial transport (Kang et al., 2008). 
While long-range movements occur along microtubules, short-range mitochondrial 
transport exploits actin filaments, particularly enriched in nerve terminals and growth 
cones. Myosins have been proposed to be the motors for such short-term transport, which 
is characterized by different properties. Myosin V and XIX have been shown to associate 
with mitochondria and to regulate mitochondrial movements over actin microfilaments 
(Pathak et al., 2010; Quintero et al., 2009). To explain why this additional transport system 
exists, it has been proposed that myosins could bring mitochondria disengaged by kinesin 
or dynein back to microtubule tracks. Alternatively, myosins may function as an additional 
docking system, removing mitochondria from microtubules and anchoring them over 
microfilament.   
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Figure 1-2. The axonal transport machinery. Schematic representation of the main proteins involved in mitochondrial 
axonal transport. KIF5 and dynein motor proteins drive mitochondria over microtubule tracks. The Miro-Milton complex 
links mitochondria to motors and regulate their transport. Syntaphilin is a static anchor that blocks mitochondria. From 
(Sheng and Cai, 2012). 
 
1.3 Regulation of mitochondrial axonal transport 
The spatial distribution of mitochondria in dendrites and axons is tightly linked to synaptic 
activity. Electron microscopy studies have shown that mitochondria associate with 
synapses and are located at sites of vesicle release (Rowland et al., 2000). Mitochondria 
are recruited to synapses to provide ATP and control local cytosolic calcium concentration 
([Ca2+]i) for neurotransmitter exocytosis, activation of ion conductances, vesicle 
recruitment and synaptic plasticity. It is not surprising therefore that the signals regulating 
mitochondrial transport at synapses are ATP and Ca2+ levels.  
When mitochondria enter sites with high ATP levels their speed increases, whereas 
increased ADP levels slow down mitochondria and recruit them to ATP depleted regions 
(Mironov, 2007).  
Intracellular Ca2+ levels represent the second signal that regulates mitochondrial transport. 
Before showing how Ca2+ is able to modulate mitochondrial axonal transport, a brief 
description of the mitochondrial Ca2+ uptake machinery is presented. 
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1.3.1 The mitochondrial Ca2+ uptake machinery  
Due to their structure, the Ca2+ uptake by mitochondria requires the crossing of both the 
outer and the inner mitochondrial membranes (OMM and IMM, respectively). Although 
commonly considered permeable to small molecules and ions, several evidences suggest 
that the OMM represents the first barrier for Ca2+ entry into mitochondria. This barrier is 
crossed by exploiting the voltage-dependent anion-selective channel (VDAC): at low 
potential, this channel is opened and weakly anion selective, whereas at high potential it is 
in the closed state and switches to cationic selectivity (Colombini, 1979). It has been 
recently shown that this channel is highly permeable to Ca2+ (Gincel et al., 2001) and is 
required for Ca2+ uptake: indeed VDAC1 overexpression increases mitochondrial matrix 
Ca2+ concentration (Rapizzi et al., 2002).  
The IMM is impermeable to ions other than H+ through the ATPase. After a long-lasting 
research, the main protein responsible for Ca2+ uptake by the IMM has been finally 
described: Rizzuto’s and Mootha’s groups identified MCU (Mitochondrial Calcium 
Uniporter) as the channel that mediates Ca2+ entry into mitochondrial matrix (Baughman et 
al., 2011; De Stefani et al., 2011). Together with other proteins, MCU forms the 
mitochondrial calcium uniporter complex (MCUC): the complexity of its structure, 
however, is not fully understood, and many proteins are emerging as components of this 
complex (Fig. 1-3). MCU represents the channel-forming subunit: it is located in the IMM, 
where it forms oligomers that constitute the channel. MCU KO in mouse skeletal muscles, 
cardiac muscles and mouse embryonic fibroblasts (MEFs) fails to increase Ca2+ levels 
inside mitochondria following Ca2+ mobilization from intracellular stores (Pan et al., 
2013). Surprisingly, MCU KO mice are regularly born and display only a mild phenotype, 
being slightly smaller than controls and showing mild muscular defects.  
In addition to the channel subunit, many MCU regulators have been identified so far. 
MICU2 is an MCU inhibitor at low Ca2+ levels, whereas MICU1 activates MCU when 
cytosolic Ca2+ is increased (Patron et al., 2014). Another recently identified MCUC 
subunit, MCUb, when overexpressed, reduces mitochondrial Ca2+ uptake following 
cytosolic Ca2+ rises (Raffaello et al., 2013). MCUR1 and EMRE have been identified as 
additional MCU regulators, modulating the opening or the assembly of the MCUC 
(Mallilankaraman et al., 2012; Sancak et al., 2013).   
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Figure 1-3. Hypothesized structure of the MCU complex. MCU forms the channel subunit of the complex, allowing 
Ca2+  entry into mitochondrial matrix. MICU1, MICU2, MCUb, EMRE and MCUR1 are regulatory elements that control 
the opening of MCU or the assembly of the complex, with inhibitory or activating effects. IMS: inter membrane space. 
From (Pendin et al., 2014).  
 
1.3.2 Ca2+-mediated modulation of mitochondrial axonal transport  
Miro has been identified as the Ca2+ sensor that regulates mitochondrial transport (Saotome 
et al., 2008; Wang and Schwarz, 2009): increased [Ca2+]i arrests mitochondrial transport 
through a Miro-Ca2+ sensing pathway that disassembles or inactivates the transport 
machinery, recruiting mitochondria to synapse. According to the classical Miro-Ca2+ 
sensing model, at resting [Ca2+]i levels KIF5 interacts with mitochondria through the Miro-
Milton complex. When moving mitochondria pass by active synapses, the local elevated 
Ca2+ levels arrest mitochondrial transport by the binding of the cation to Miro’s Ca2+ 
sensing EF hands. The Miro-Milton-kinesin complex is inactivated and mitochondria are 
immobilized at synapses. Two studies proposed different mechanisms to explain how the 
motor-adaptor complex mediates mitochondrial transport arrest. Wang and Schwarz (Fig. 
1-4 A) proposed that Ca2+ binding by Miro induces KIF5 to disconnect with microtubules 
(Wang and Schwarz, 2009); alternatively, Ca2+ binding by Miro releases KIF5 from 
mitochondria (Fig. 1-4 B) (Macaskill et al., 2009). These two models differ as to whether 
kinesin remains associated to mitochondria or not: this may be explained by their selective 
observations of mitochondrial axonal transport in axons vs dendrites. 
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Figure 1-4. Regulation of axonal mitochondrial transport. A) Ca2+ binding to Miro induces kinesin to detach from 
microtubules. B) Alternatively, Ca2+ binding releases kinesin from mitochondria. C) Ca2+
 
sensing by Miro triggers the 
binding switch of kinesin from the Miro-Milton complex to syntaphilin, which anchor mitochondria. From (Sheng, 
2014). 
 
Despite the fact that Miro-Ca2+ regulation affects both anterograde and retrograde axonal 
transport, the transport arrest triggered by Ca2+ is not observed in syntaphilin null neurons 
(Chen and Sheng, 2013). This led to the hypothesis that mitochondria are immobilized by 
an anchoring mechanism. Syntaphilin competes with Milton for binding to kinesin and 
inhibits kinesin motor ATPase activity in vitro (Chen and Sheng, 2013). Taking into 
account these new findings, a new “engine switch and brake” model was recently proposed 
(Fig. 1-4 C). In response to elevated [Ca2+]i, the Miro-Ca2+ sensing pathway triggers the 
binding switch of kinesin from the Miro-Milton complex to syntaphilin, which anchors 
axonal mitochondria and inhibits kinesin motor ATPase activity. However, kinesin remains 
associated with stationary mitochondria, in order to quickly re-mobilize them when the 
Ca2+ signal is removed.  
A 
	   
	   
B 
C 
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Recent evidence argued against this general view of Miro/Ca2+ mediated regulation of 
mitochondrial transport. Nguyen and colleagues have demonstrated that the loss of MIRO1 
in mice did not prevent the Ca2+-dependent arrest of mitochondria, suggesting that MIRO2 
or an alternative Ca2+ sensing pathway may regulate the axonal transport of these 
organelles (Nguyen et al., 2014). In addition, the level of Ca2+ inside mitochondrial matrix 
has been shown to inversely correlate with mitochondrial speed, and Ca2+ influx through 
MCU is sufficient to arrest mitochondrial transport (Chang et al., 2011). These findings 
demonstrate that our understanding of the regulation of mitochondrial axonal transport is 
still incomplete, and further studies are required to elucidate the mechanisms involved.   
      
1.4 Mitochondrial transport, dynamics and mitophagy  
The classic life-cycle of mitochondria is here summarized: mitochondrial biogenesis 
mainly occurs in the soma, where mitochondria exist in the form of a highly interconnected 
network and single bean-shaped mitochondria. Mitochondrial fragmentation, mediated by 
Drp1 (dynamin-related protein), generates mitochondria whose size is compatible with 
axonal transport. Once in the axon, mitochondria age, accumulating mutations in the mt-
DNA and producing ROS; eventually, they are transported back to the cell body, where 
they undergo mitophagy or fusion with functional mitochondria. Although this classical 
view is largely accepted, fission-fusion events and DNA replication have been shown to 
occur also in axons (Amiri and Hollenbeck, 2008), thus questioning the meaning of 
mitochondrial transport. However, the axoplasm has only a modest translation capacity and 
most genes encoding mitochondrial proteins are nuclear genes, making massive local 
biogenesis debatable. Being biogenesis mainly localized in the soma, mitochondrial 
dynamics play an important role in mitochondrial transport. The size of a mitochondrion 
correlates with its mobility pattern: elongated mitochondria in fission-deficient neurons 
accumulate in the soma, whereas they are depleted in synapses and dendrites (Li et al., 
2004). Drp1-mediated mitochondrial fission is required to deliver mitochondria to 
Drosophila neuromuscular junctions (Verstreken et al., 2005). MFN2, one of the proteins 
involved in mitochondrial fusion, interacts with MIRO2 and modulates motor processivity 
or the switch between dynein and kinesin (Misko et al., 2010).  
Concerning mitochondrial degradation, localized mitophagy occurs in the distal neuronal 
axons (Ashrafi et al., 2014), providing a mechanism to protect neurons from ROS-induced 
damage. However, as well as for biogenesis, the autophagic machinery is mainly located in 
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the soma, requiring damaged mitochondria to be transported back to the soma by 
retrograde transport: once in the cell body, they can be either degraded or fused with 
functional mitochondria. 
 
1.5 Axonal transport defects and neurodegenerative diseases 
Alterations of axonal transport have recently emerged as a common feature in many 
neurodegenerative diseases. In these disorders, cargoes, that are usually transported along 
the axon, display an altered distribution, accumulating in the soma, the proximal part of the 
axon or axon terminals. Some examples are shown below: 
• Alzheimer’s disease (AD): mutations in APP (amyloid precursor protein), PSEN1 
or MAPT (microtubule-associated protein tau) genes affect fast axonal transport. 
Axonal transport defects are found in transgenic mice overexpressing wt or mutant 
APP (Salehi et al., 2006), mutant PS1 (Lazarov et al., 2007) and wt or mutant tau 
(Zhang et al., 2004). Overexpression of wt or mutated APP disrupts nerve growth 
factor (NGF) retrograde transport (Salehi et al., 2006). Mutant PS1 can activate 
glycogen synthase kinase 3β (GSK3β), which phosphorylates kinesin light chains 
(KLCs), releasing cargoes from motors (Pigino et al., 2003). Moreover, Aβ itself is 
able to impair axonal transport of vesicles and mitochondria by promoting actin 
polymerization and aggregation or through an NMDA-type glutamate receptor 
dependent mechanism (Decker et al., 2010; Hiruma et al., 2003). In addition, wt tau 
can inhibit transport by activating GSK3β, which phosphorylates KLCs releasing 
kinesin from cargoes (LaPointe et al., 2009). Hyperphosphorylated tau, which 
accumulates intracellularly during AD, might destabilize axonal microtubules 
leading to neuronal degeneration (Wagner et al., 1996).   
• Hereditary spastic paraplegia (HSP): many genes associated with HSP are involved 
in axonal transport. Mutations in the gene encoding spastin (SPG4 or SPAST) 
account for the 40% of autosomal dominant forms of HSP. Mutant spastin 
interferes with kinesin-mediated transport of organelles and neurofilaments 
(McDermott et al., 2003). Another gene mutated in dominant forms of HSP is 
KIF5A: mutations mostly impairs microtubule affinity or transport velocity (Ebbing 
et al., 2008). Conditional KO mice for Kif5A show a reduction in neurofilament 
axonal transport (Xia et al., 2003).  
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• Charcot-Marie-Tooth disease (CMT): mutations in the gene encoding for mitofusin 
2 (MFN2) have been associated with a specific form of CMT, CMT2A (Züchner et 
al., 2004). MFN2 has been shown to be involved in mitochondrial axonal transport: 
mutant MFN2 expressing mice show mitochondrial aggregation in the axon and in 
the distal part of motor neurons (Cartoni et al., 2010; Detmer et al., 2008) and, in 
vitro, mutated MFN2 alters both anterograde and retrograde axonal mitochondrial 
transport (Baloh et al., 2007). These effects are mediated by the interaction of 
MFN2 with the MIRO/TRAK complex: mutated MFN2 alters the function of this 
complex, leading to an impaired mitochondrial transport (Misko et al., 2010). 
Mutations in other genes responsible for other forms of CMT (TBCD15, NEFL) 
alter endosomal, lysosomal or neurofilament transport.  
• Amyotrophic lateral sclerosis (ALS): mutated superoxide dismutase 1 (SOD1G93A) 
reduces anterograde mitochondrial transport, increasing their retrograde 
translocation. This lead to a depletion in the number of mitochondria in the axon 
(De Vos et al., 2007).    
As emerged from this list, axonal transport defects can have different origins: loss-of-
function mutations in motor proteins may deregulate axonal transport; mutant or 
misfolded proteins might interfere with the transport machinery, leading to neuropathy; 
mitochondrial dysfunction can affect the axonal transport of cargoes. Although the list 
of genes above is synthetic and not complete, it clearly shows that alterations of axonal 
transport may contribute to neurodegeneration. Whether these alterations are the cause 
or the consequence of neurodegeneration is still subject of debate. The association 
between several mutations in genes encoding proteins involved in axonal transport and 
neurodegenerative diseases suggests that alterations in this functionality can trigger 
neurodegeneration. However, recently it has been shown that impairments of 
mitochondrial transport may not be the direct cause of motor neuron degeneration in 
ALS (Marinkovic et al., 2012), suggesting that organelle transport deficits may 
accelerate rather than cause neurodegeneration. Future studies are needed to determine 
how alterations in axonal transport trigger neurodegeneration, providing new 
therapeutic targets to restore neuronal function and survival.  
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1.6 Zebrafish as a tool to study mitochondrial biology and 
diseases  
In the past decades, the tropical freshwater fish Danio rerio, commonly named zebrafish, 
has emerged as a vertebrate system to study human diseases, representing an efficient 
alternative to rodents. This popularity is due to its rapid development, its ability to produce 
hundreds of eggs, transparency of embryos, low costs of maintenance, the ease of testing 
drugs and the availability of genetic tools to alter gene expression. The zebrafish genome is 
strikingly similar to the human one, and approximately 70% of human genes have at least 
one orthologue in zebrafish (Howe et al., 2013). Some genes, however, may have two 
orthologues, due to a genome duplication that occurred early in teleosts: usually in this case, the 
two duplicated genes play the same function. As for nuclear genome, mitochondrial DNA 
(mtDNA) is highly conserved, with a 70% identity with human mtDNA and the same set of 37 
genes. Despite 420 million years of divergence, zebrafish central nervous system (CNS) basal 
structure and function is conserved: most areas that are affected in human diseases have their 
anatomical homologous counterpart in zebrafish CNS. This is the case, for example, for the 
dopaminergic system, whose degradation is reported in Parkinson’s disease (PD): zebrafish has 
dopaminergic neurons (DA) distributed in the telencephalon, pretectal area and ventral 
diencephalon (Rink and Wullimann, 2001). pink1 or parkin KD in zebrafish led to a reduction in 
the number of DA neurons in the CNS, although these findings are conflicting (Flinn et al., 2009; 
Sallinen et al., 2010).  
The list of mitochondrial diseases modelled in zebrafish is longer than here described: CMT2A, 
ALS, Goldberg-Shprintzen syndrome and dominant optic atrophy are just some examples.  
• CMT2A is caused by MFN2 mutations and characterized by muscular weakness and 
atrophy, motor neuron axonal degeneration, distal sensory loss and foot deformities. 
MFN2 is a mitochondrial protein located in the OMM, involved in mitochondrial fusion 
and ER-mitochondria tethering (de Brito and Scorrano, 2014). mfn2 morphants show an 
altered pattern of the axons of caudal primary motor neurons, reduced formation of 
neuromuscular junctions and muscular abnormalities, closely reproducing a CMT2A 
phenotype (Vettori et al., 2011).  
• Another pathology in which motor neurons are lost is ALS. Gain-of-function mutations in 
SOD1 have been linked to familial and sporadic ALS. Normally, SOD1 is a cytosolic 
protein, localizing also in the mitochondrial intermembrane space. Mutated SOD1 
accumulates in the intermembrane space, increasing oxidative stress. Overexpression of 
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mutated SOD1 (G93A, G37R and A4V) in zebrafish alters motor neurons branching and 
length (Lemmens et al., 2007).  
• Mutations in KIF1-binding protein (KBP) cause the Goldberg-Shprintzen syndrome. KBP 
localizes to mitochondria and interacts with KIF1Bα, a motor protein involved in 
mitochondrial transport. kbp KD in zebrafish induces axonal defects in the nervous system, 
alterations in axon myelination, microtubule organization and distribution of axonal 
mitochondria (Lyons et al., 2008).  
• Dominant optic atrophy is caused by mutations in the OPA1 gene, encoding for a 
mitochondrial protein involved in the fusion of inner membranes, cristae remodelling and 
cytochrome c release. The disease is characterized by atrophy of the optic nerve and loss of 
retinal ganglion cells, leading to the loss of vision. Although neither loss of retinal ganglion 
cells nor optic atrophy were observed at 48 and 72 hpf  in opa1 morphants, they do display 
some development defects. Moreover, mitochondria were fragmented upon opa1 KD 
(Rahn et al., 2013).  
 
1.7 Mitochondrial axonal transport in zebrafish sensory 
neurons 
In the past years, cell lines and primary neuronal cultures from mice have been broadly 
used to study mitochondrial axonal transport in neurons. Although these approaches 
allowed the discovery of new modulators of mitochondrial transport, they have important 
limitations. Cell culture-based studies are limited to an artificial environment, where 
stimuli coming from other cells are absent or few and neurons lack support from glia and 
from other cell types. Transgenic mice selectively expressing mitochondria-targeted 
fluorescent proteins in neurons have been generated to better mimic a physiological 
situation. Although these mice represent a more reliable model, imaging is challenging due 
to their anatomy: surgery is required to track mitochondrial transport in neurons, and drugs 
are difficultly delivered to the nervous system. Generation of transgenic mice expressing 
mutations in specific genes (knock in, KI) or with inactivated genes (KO) is time-
consuming, and nervous system restriction of transgene expression is sometimes difficult 
to fulfil. Invertebrate models represent an attractive option, because of the ease to 
manipulate them and to restrict gene expression in a cell-specific manner. However the low 
conservation of invertebrates genome with the one of vertebrates and especially of 
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mammals and the highly different nervous system physiology and organization, as for 
example the lack of myelination, represent important limitations for their use as models for 
human neurodegenerative diseases.  
Recently zebrafish has shown to be a powerful tool to study mitochondrial dynamics in 
vivo, due to several advantages: embryos are transparent, making imaging simpler; 
myelination makes zebrafish neurons more similar to human ones and many tools are 
available to alter gene expression by morpholino injection, targeted gene disruption or site 
directed mutagenesis. 
Mitochondrial labelling can be easily fulfilled using either chemical probes or fluorescent 
proteins. Chemical probes directly dissolved in fish water have been used to label 
mitochondria accordingly to their activity (MitoTracker) (Lin et al., 2006), or ROS 
production (dihydrorhodamine 123) (Song et al., 2009)). Alternatively, genetic labelling of 
mitochondria with fluorescent proteins (CFP, DsRed or Kaede targeted to mitochondria 
through the human  mitochondrial targeting sequence of CoxVIII) represents a more stable 
and efficient option.  
This latter strategy has been recently exploited by two different groups to study 
mitochondrial axonal transport in RB sensory neurons (O’Donnell et al., 2013; Plucińska et 
al., 2012).   
 
1.8 Rohon-Beard sensory neurons: the best choice to track 
mitochondria in zebrafish 
Zebrafish somatosensation is performed by three classes of sensory neurons: trigeminal 
neurons, that innervate the head; Rohon-Beard (RB) neurons, that innervate the body early 
during development and dorsal root ganglia (DRG) neurons, that replace RB neurons at 
later stages (Palanca et al., 2013). RB neurons are mechanosensory neurons located in the 
dorsal part of the zebrafish spinal cord, forming two continuous rows on each side of the 
embryo (Reyes et al., 2004). Their main peculiarity is the presence of two central axons 
(one extending rostrally and the other caudally) and a peripheral axon that is responsible 
for skin innervation. RB cells undergo apoptosis by 3-4 dpf, replaced by DRG neurons. 
Due to their long axons, RB neurons represent an excellent system to study the axonal 
transport of mitochondria in vivo: mitochondria can be easily tracked over long distances 
by time-lapse confocal imaging. Since mitochondria exhibit fast axonal transport and 
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undergo fusion/fission events in the axon, it is crucial to discriminate single mitochondria 
by using high magnifications and resolutions: the superficial location of RB neurons makes 
this possible, allowing the use of high magnification objectives (100X) more difficult to 
use with other types of neurons.  
Mitochondrial axonal transport has been recently characterized in a zebrafish transgenic 
line expressing mito-CFP (MitoFish) in RB neurons (Plucińska et al., 2012). Time-lapse 
imaging was used to track mitochondria and measure the main parameters of the transport, 
such as mitochondrial fluxes, average and moving speeds. After a characterization of these 
parameters during development, MitoFish were crossed with a line expressing mutated tau 
(Taufish). The authors observed a reduction in the density of total and moving 
mitochondria as well as in their average speed, whereas moving speed was increased. The 
transport parameters measured in this system closely resemble transport characteristics of 
previously described mammalian systems; in addition, alterations of mitochondrial 
transport properties were detected under pathological conditions.  
A similar system was used to analyze mitochondrial axonal transport in a mito-DsRed fish 
(O’Donnell et al., 2013) undergoing Wallerian degeneration (WD), a stereotyped program 
that leads injured axons to degeneration. WD is strongly delayed by the Wallerian 
degeneration slow protein (Wlds): recent studies suggest that Wlds protective role is 
mediated by mitochondria, and axon protection may be related to mitochondrial transport. 
Mitochondrial transport was completely arrested in the axonal segment immediately distal 
to the injury site. Wlds overexpression, although sufficient to strongly delay axon 
degeneration, was not able to prevent mitochondrial transport arrest neither acutely nor 
later after injury, suggesting that mitochondrial motility is not required for the maintenance 
of axonal integrity. Indeed the authors demonstrated that alterations in mitochondrial redox 
state rather than in mitochondrial transport correlate with axon degeneration.   
 
1.9 Alzheimer’s disease 
1.9.1 AD pathology 
Alzheimer’s disease (AD) is the most common form of dementia in the aged population, 
with more than 35 million people estimated to be affected worldwide 
(http://www.alz.co.uk). Due to increased life longevity, this number is expected to increase 
dramatically in the coming years. Clinically, AD is characterized by progressive memory 
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and cognition impairments, emergence of psychiatric symptoms and behavioral disorders 
(including depressions, delusions and hallucinations) and impairment of activities of day 
living (Hong-Qi et al., 2012). 
AD is generally classified in two groups: late onset AD (LOAD) and early onset AD 
(EOAD). LOAD occurs after 65 years of age and is the most common form of the disease, 
accounting for almost 95% of cases. It is associated with many risk factors, including 
hormonal changes, diet, hypercholesterolemia, hypertension, obesity and type II diabetes. 
In addition to environmental factors, a growing number of loci have been identified to 
represent a risk for developing LOAD: the ε4 allele of the apolipoprotein gene is the most 
known (Corder et al., 1993).   
EOAD is the most rare form of AD and accounts for a small percentage of cases: despite 
this, it is the most severe form. The age of onset is below 65 years, and can be as young as 
25 years. In contrast to LOAD, where genetic and environmental risk factors cooperate, 
EOAD is generally represented by familial forms of AD (FAD) caused by mutations in 
three genes: APP, PSEN1 and PSEN2.  
APP encodes for the glycoprotein from which the Aβ peptide originates by the consecutive 
cleavage of β- and γ-secretase. Mutations in APP increase Aβ production or the isoform of 
Aβ produced, pointing towards more fibrillogenic forms.  
Mutations in PSEN1 and PSEN2 account for the rest of FAD cases. Presenilins (alias PS1 
and PS2) are membrane-spanning proteins characterized by 9 transmembrane domains 
(Fig. 1-5); they are endo-proteolytically cleaved in a N-terminal fragment (NTF, facing the 
cytosol) and a C-terminal fragment (CTF, facing the extracellular space or the lumen). 
Presenilins form the catalytic core of the γ-secretase complex, located both at the plasma 
membrane and intracellular membranes (ER and Golgi). NOTCH is one of the proteins 
processed by the γ-secretase: its cleavage releases the NOTCH intracellular domain 
(NICD), which translocates to the nucleus where it activates NOTCH-responsive elements. 
Similarly to NOTCH, the γ-secretase cleavage of APP releases the APP intracellular 
domain (AICD), which translocates to the nucleus, and the Aβ peptide: mutations in 
presenilin genes alter the levels or type of Aβ produced. Over 170 autosomal mutations in 
PSEN1 and more than 10 in PSEN2 have been reported so far: most of them are missense 
mutations that result in single amino acid substitutions.  
Most we know on AD pathogenesis comes from FAD, since the genes involved in the 
disease have already been discovered and a growing number of animal models are 
unraveling their pathogenetic mechanisms. 
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Figure 1-5. Schematic representation of presenilin 1. Presenilin 1 amino acid (aa) sequence, topology and mutations 
are shown. In red aa residues substituted by FAD causing mutations. In blue aa involved in protein interactions. From 
(De Strooper et al., 2012). 
 
Although the causes of LOAD and EOAD are different, the two types of AD share 
common neuropathological hallmarks, firstly identified by Alois Alzheimer in 1907 
(Alzheimer et al., 1995): neurofibrillary tangles and amyloid plaques (Fig. 1-6). 
Neurofibrillary tangles are constituted by hyperphosphorylated tau, whereas amyloid 
plaques are composed of Aβ peptide aggregates: during the course of AD, 
hyperphosphorylated tau and Aβ form extra- and intracellular deposits.  
Tau is a microtubule-binding protein that promotes microtubule assembly and stability, by 
binding to the plasma membrane through its N-terminus and to microtubules through its C-
terminus. Although being expressed in many tissues, tau is highly enriched in neurons, in 
particular in the axon (Binder et al., 1985): here its distribution is not continuous but 
reflects a gradient, with the highest concentration at synapses (Mandell and Banker, 1996), 
where it may favour cargo release. Tau function is controlled by its phosphorylation state: 
hyperphosphorylation at its many serine, threonine and tyrosine residues inhibits tau 
microtubule-stabilizing properties (Lindwall and Cole, 1984).  
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Figure 1-6. Inclusions in AD. A) Senile plaques composed by aggregation of Aβ peptide. B) Tau-positive neurofibrillary 
tangles, neutrophil threads and dystrophic neurites. Scale bar: 100 µm. From (Haass and Selkoe, 2007). 
Under physiological conditions, tau phosphorylation has the purpose of regulating tau 
activity during development, allowing neurons to maintain their microtubule network and 
their functionality.  In AD brain tau is phosphorylated ∼  3 fold more than in normal brains: 
hyperphosphorylated tau sequesters normal tau, promotes microtubule assembly disruption 
and the misfolding of normal tau and other aggregates into filaments (Alonso et al., 1997).  
These events lead to alterations in the axonal transport of cargoes (Salehi et al., 2003), 
inhibition of axon outgrowth triggering a “dying back” process (Yang et al., 2007) and to a 
decrease of proteasome activity (Ren et al., 2007), resulting in a vicious cycle that favors 
protein aggregation. Tauopathy is first observed in the entorhinal cortex, and then spreads 
throughout the brain from neuron to neuron via synaptic connections, leading to 
aggregation of intranueronal tau.  
Aβ  peptide and tau aggregates have been regarded as being either involved in AD 
pathogenesis or a protective response of the cell to oligomers toxicity. Dealing with this 
latter it is worth mentioning that Aβ soluble oligomers, rather than Aβ plaques, have been 
particularly implicated in AD pathogenesis (Haass and Selkoe, 2007).   
The two main hypothesis thought to be able to explain AD pathology are shown below. 
 
1.9.2 The amyloid hypothesis 
The “amyloid hypothesis” identifies Aβ peptide as the main cause for the onset of AD. Aβ 
peptide is normally produced by the consecutive action of β- and γ-secretase on APP (Fig. 
1-7 A, B). APP processing by the β-site APP cleaving enzyme 1 (BACE-1) results in the 
extracellular secretion of the large APP ectodomain; the remaining membrane-bound 
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fragment (CTFβ) is cleaved by the γ-secretase, generating the Aβ peptide and the APP 
intracellular domain (AICD).  Many Aβ isoforms are produced varying in length between 
38-42 amino acids: these isoforms have different ability to aggregate and form the typical 
Aβ plaques found in AD: Aβ42 is particularly prone to aggregate and form extracellular 
deposits. 
According to the amyloid hypothesis, changes in the steady-state levels of Aβ are the 
initial step that triggers a cascade of alterations, eventually leading to neuronal 
dysfunction, degeneration and death. Increase in Aβ42 levels causes the appearance of 
plaques in the brain parenchima: plaque formation is accompanied by vascular injury and 
inflammation, with the release of damaging cytokines by activated microglia and 
astrocytes. This results in the production of an inflammatory milieu that provokes the 
destruction of the blood vessel barrier and neuritic changes, including synaptic injury (Fig. 
1-7 C), oxidative stress, ionic homeostasis and biochemical dysfunction; tau is 
phopshorylated as a consequence of an altered kinase and phosphatase activity. Eventually 
this cascade terminates with a general neuronal dysfunction and cell death, resulting in 
dementia. 
This hypothesis is supported by genetic studies that identified mutations in APP, PSEN1 
and PSEN2 genes as the cause of FAD; all these three genes are involved in Aβ production 
and their mutations increase Aβ levels or the isoform of Aβ produced, pointing towards 
more aggregation prone forms (Aβ42). 
Although being an attractive explanation for AD pathogenesis, the amyloid hypothesis is 
not supported by several evidences. First of all, Aβ deposition does not correlate with the 
degree of dementia, and some Aβ plaques can be found in brains of old unaffected people. 
In addition, a number of drugs developed to reduce Aβ production or aggregation have 
failed human clinical trials (AlzhemedTM, NSAID, FlurizanTM). To justify these findings, it 
has been argued that blood-brain barrier penetration problems and the advanced state of 
patient in the disease may explain this failure. On the contrary, drugs not directed against 
Aβ are actually in phase IIIb trials (e.g., Latrepirdine), arguing that other pathways may be 
involved in AD pathogenesis. This is further supported by the evidence coming from 
animal models: transgenic FAD mice carrying mutations that lead to Aβ accumulation, 
although showing cognitive defects, do not show dramatic neurodegeneration (Woodruff-
Pak, 2008). Neurodegeneration has been described in “3xTG-AD” mice carrying mutations 
in APP, PSEN1 and MAPT (Oddo et al., 2003) or “5xFAD” mice, with three mutations in 
APP and two mutations  
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in PSEN1 alleles (Oakley et al., 2006). This situation, however, does not resemble FAD 
pathogenesis, where a mutation in only one gene is sufficient to induce neuronal loss. 
These findings may suggest alternatives to the amyloid hypothesis. 
 
Figure 1-7. Aβ production and its effects on synapses. A) Amyloidogenic processing of APP is initiated by β-secretase 
(BACE) activity, that leads to the secretion of the ectodomain. The remaining membrane-bound CTFβ fragment is 
cleaved by γ-secretase complex, composed by PS1 or PS2, nicastrin (NCT), PEN2, and APH1a or APH1b. PS1 or PS2 
represent the catalytic core of the complex; PSs are endoproteolitically cleaved to generate a N-terminal and C-terminal 
fragment (NTF and CTF, respectively). γ-secretase cleavage produces the Aβ peptide and the APP intracellular domain 
(AICD). B) Sites of proteolysis by γ-secretase. The  γ-site is the most relevant for AD pathogenesis. From (Haass and 
Selkoe, 2007). C) Effects of β-amyloid peptide on synapses. A control synapse is shown in the top of the figure; the 
synapse below depicts synaptic dysfunction in AD. From (Querfurth and LaFerla, 2010).   
 
1.9.3 The Ca2+ hypothesis  
The “Ca2+ hypothesis” was firstly described by Khachaturian in 1989: he proposed that 
sustained dysregulation of neuronal Ca2+ signaling pathways is the main cause of 
neurodegeneration observed in AD (Khachaturian, 1989). Although initially promoted 
without any evidence, a growing number of experimental and human systems is now 
supporting the importance of Ca2+ dyshomeostasis in the pathogenesis of AD. Data 
collected from both patients and experimental models show that alterations in Ca2+ 
signaling occur even before the appearance of observable symptoms and extracellular Aβ 
deposition (Etcheberrigaray et al., 1998; Larson et al., 1999). These findings suggest that 
Ca2+ alterations precede Aβ deposition; however, it still remains unclear which step occurs 
first in AD pathogenesis, since different studies reached contrasting conclusions. This is 
further complicated by the reciprocal influence that APP and Ca2+ homeostasis have on 
each other. Virtually, every product of APP cleavage is able to modulate Ca2+ signaling, 
although the final outcome may be different. Secreted APP (APPs) attenuates the increased 
intracellular Ca2+ levels due to cellular insults such as Aβ peptide itself (Goodman and 
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Mattson, 1994), and protects cells from excitotoxicity and apoptosis (Guo et al., 1998; 
Mattson et al., 1993). While APPs may have a neuroprotective role, the Aβ peptide alters 
neuronal Ca2+ homeostasis: increased Ca2+ resting levels have been found both in 
pyramidal neurons (in the neocortex) close to Aβ deposits (Kuchibhotla et al., 2008) and in 
cortical neurons of 3xTg-AD mice (Lopez et al., 2008). As APP derivatives affect Ca2+ 
homeostasis, the opposite is also true. Both elevated cytosolic Ca2+ levels in human 
embryonic kidney cells that overexpress a FAD-APP mutant (Querfurth and Selkoe, 1994) 
and caffeine-stimulated Ca2+ release from internal stores (Querfurth et al., 1997) increase 
Aβ secretion. It is becoming clear that, rather than be an alternative to the amyloid 
hypothesis, the Ca2+ hypothesis may explain how Aβ production and aggregation lead to 
neurodegeneration and memory loss (Fig. 1-8).  
But how does Ca2+ signaling dysregulation occur? Remodeling of Ca2+ signaling pathways 
primarily involves both the entry of external Ca2+ inside the cell and the release from 
internal stores. Aβ42 oligomers have been proposed to enhance Ca2+ entry by either 
functioning as channels or by activating receptor-operated channels, such as NMDA 
receptors (Kagan et al., 2002). The boosted Ca2+ entry inside the cell leads, as a main 
consequence, to an increased amount of Ca2+ released from internal stores, in particular 
from the ER. Indeed, in most cases, ER Ca2+ release is increased: a large body of evidence 
from Xenopus oocytes, cell lines and transgenic mice shows an enhanced InsP3 evoked 
Ca2+ release from the ER upon mutant presenilins expression. The classical explanation of 
these results was the “Ca2+-overload” hypothesis in which CALHM1 and presenilins have 
been identified as the main players. The calcium homeostasis modulator 1 (CALHM1) has 
been proposed to form leak channels (Dreses-Werringloer et al., 2008): this protein is 
located at both the plasma membrane and the ER and may function as a pore-forming ion 
channel. Variants in the CALHM1 gene may constitute a risk factor for LOAD: the 
CALHM1 polymorphism associated with an increase in developing AD reduces Ca2+ 
permeability, resulting in an increase in ER-Ca2+ stores. As CALHM1, presenilins have 
been proposed to form leak channels in ER membranes, with FAD-linked mutants 
reducing this passive leaks (Tu et al., 2006). In addition, presenilins have been reported to 
enhance SERCA pump activity (Green et al., 2008) too: in both cases this results in 
increased Ca2+ levels inside the ER, supporting the Ca2+ overload.  
Despite being an attractive explanation for AD neurodegeneration, recent evidences have 
challenged the Ca2+ hypothesis. Several independent works have shown that FAD-linked 
PS1 overexpression does not result in an increase of the ER Ca2+ content, leaving it 
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unchanged or even modestly reduced (McCombs et al., 2010; Shilling et al., 2012; Zatti et 
al., 2006). Similarly, FAD-linked PS2 overexpression has been shown to reduce the Ca2+ 
content of intracellular stores (Giacomello et al., 2005; Kipanyula et al., 2012; Zampese et 
al., 2011a; Zatti et al., 2004, 2006), by reducing SERCA pumps activity and increasing ER 
Ca2+ leak across IP3 Ca2+ channels (Brunello et al., 2009). Rather than leading to a “store 
overload”, presenilins have been found to enhance IP3R single channel gating and 
sensitivity, resulting in an exaggerated ER Ca2+ release (Cheung et al., 2008, 2010). 
Presenilins can influence intracellular Ca2+ signaling also indirectly by modulating APP 
cleavage.  
 
Figure 1-8. The calcium hypothesis. Amyloid metabolism is thought to remodel Ca2+
 
signaling, leading to synaptic 
disruption and neuronal cell death. 1) Aβ oligomers may increase Ca2+ entry inside the cell by functioning as channels or 
by activating other channels (e.g., NMDARs). 2) AICD acts as a transcription factor in the nucleus, increasing RYR and 
decreasing calbindin expression. 3) Ca2+
 
signaling is upregulated in AD. Mutated presenilins alter ER Ca2+
 
content. 4) 
The Ca2+ dysregulation disrupts synapses and triggers mitochondria-mediated apoptosis. From (Berridge, 2010).   
 
AICD production increases the expression of ryanodine receptors (RYRs) and 
downregulates calbindin, a Ca2+ buffer that restricts the amplitude of Ca2+ signals: AD 
patients display a reduction in calbindin immunoreactive neurons in the cerebral cortex 
(Ichimiya et al., 1988), suggesting that this protein may play a role AD pathogenesis.  
Ca2+-signaling remodeling eventually lead to disruption of synaptic plasticity and cell 
death by activating long-term depression of synapses and inhibiting long-term potentiation. 
On the other hand, the Ca2+ remodeling may trigger mitochondria-mediated apoptosis: 
firstly, elevated Ca2+ levels inside mitochondrial matrix may increase ROS production; 
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secondly, an increase in Ca2+-uptake by mitochondria (as a consequence of the increase in 
Ca2+-release from ER in AD) could lead to the opening of the mitochondrial permeability 
transition pore (MPTP), releasing cytochrome c and activating caspases. 
These findings suggest that the amyloid and calcium hypothesis together could explain the 
early steps in the onset and progression of AD. However many questions remain 
unanswered, indicating that new animal models and studies are required to further 
characterize AD pathogenesis.   
 
1.9.4 Presenilin 2 modulates ER-mitochondria interactions 
Despite reducing ER Ca2+-content, PS2 has been reported to increase the physical and 
functional interaction between ER and mitochondria (Fig. 1-9 A-D) (Zampese et al., 
2011a). FAD-PS2-T122R overexpression in SH-SY5Y cells and rat cortical neurons leads 
to an increase in ER-mitochondria tethering, whereas the opposite is seen upon PSEN2 
down-regulation. In addition, PS2-T22R overexpression increases Ca2+ transfer from ER to 
mitochondria and Ca2+ hot spots generated at the OMM. Surprisingly, all these effects are 
specific for PS2, since PS1 overexpression or down-regulation is without effect. PS1 and 
PS2 are highly homologous proteins that have both similar and distinct roles. PS1 leaves 
ER Ca2+ content almost unchanged and is not involved in the modulation of ER-
mitochondria interaction. By contrast, PS2 is able to inhibit SERCA pump activity, 
decreases ER Ca2+ content but increases Ca2+-transfer from the ER to mitochondria making 
these two organelles closer. The increased ER-mitochondrial interaction could represent an 
attempt to compensate for the reduced ER Ca2+ content (Fig. 1-9 F); alternatively, it may 
represent a toxic mechanism that triggers mitochondrial Ca2+ overload (Fig.1-9 G), 
eventually leading to apoptosis (Zampese et al., 2011b).  
According to this hypothesis, mitochondrial dysfunction is one of the most clear and early 
features in AD. Mitochondria display damages at several levels: deficiency in several 
enzymes of oxidative metabolism (Reddy and Beal, 2008), increased oxidative stress (Zhu 
et al., 2006) and an altered calcium homeostasis (Keller et al., 1998) have been previously 
described. 
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Figure 1-9. PS2-mediated ER-mitochondria interactions. A-C) Confocal images of SH-SY5Y cells co-expressing a 
mitochondria-targeted RFP (mit-RFP) and a ER-targeted GFP (ER-GFP). FAD-PS2-T122R overexpression increases 
ER-mitochondria tethering, as revealed by yellow color. D) 3D representation of the distribution of Ca2+ hot sposts on the 
OMM. E) In physiological conditions, mitochondria receive Ca2+ 
 
signals from the ER that regulate their activity. FAD-
PS2 mutants reduce ER Ca2+ content and increase ER-mitochondria tethering. F) The increased tethering could represent 
a mechanism to compensate for the reduction in ER  Ca2+ content, positioning mitochondria closer to ER  Ca2+
 
release 
sites. G) Alternatively, the increased tethering and Ca2+
 
transfer may represent a pathological condition, triggering the 
apoptotic cascade. From  (Zampese et al., 2011b). 
 
 
In addition to these functional abnormalities, mitochondrial morphology and distribution 
within the cell result altered as well. A high number of mitochondria with broken cristae 
and a decreased overall number of organelles were observed in AD neurons lacking 
neurofibrillary tangles (Hirai et al., 2001), suggesting that alterations in mitochondrial 
dynamics represent an early step in AD pathogenesis. Moreover, APP overexpression leads 
to mitochondrial fragmentation (Wang et al., 2008a), an event that may eventually result in 
mitochondrial damage in neurons, and perinuclear mitochondria clusters have been 
observed in sporadic AD fibroblast (Wang et al., 2008b). Therefore it has been proposed 
that defects in mitochondrial distribution in AD neurons may fail to sustain neuronal 
functions, causing energy and Ca2+ defects that eventually lead to synaptic dysfunction.        
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1.10 Presenilins animal model for AD 
1.10.1 Mouse models 
To better understand presenilins function, KO and transgenic mice have been generated in 
the past years. Psen1 KO mice somehow resemble a Notch KO phenotype, showing axial 
skeleton deformations, CNS abnormalities, somite segmentation and differentiation defects 
(Shen et al., 1997). Neuron loss is also reported in the ventricular zones and sub-
ventricular zones of the ventro-lateral region: loss of Psen1 affects neuronal development 
in several brain regions. However Psen1 KO mice show perinatal lethality, precluding the 
analysis of adult phenotypes. To overcome this limitation, conditional KO mice have been 
generated. Psen1 was depleted in the hippocampus and neocortex by expressing Cre 
recombinase under the control of the CamKIIα promoter, eliminating Psen1 expression 
from the third postnatal week (Feng et al., 2001). Mice are viable and do not present 
evident phenotypic alterations; as a consequence of Psen1 ablation, Aβ peptide formation 
is decreased (Yu et al., 2001). Similar data were found in another conditional KO mouse 
under the Thy-1 promoter (Dewachter et al., 2002). In any case, Psen1 conditional KO 
does not change the number of neurons or glia in the dentate gyrus of the hippocampus in 
adult brains.  
Unlike Psen1 KO mice, Psen2 KO animals are viable and fertile and show only mild 
pulmonary abnormalities, without CNS defects (Herreman et al., 1999). Psen2 ablation 
does not alter APP processing or apoptotic processes, suggesting that mutations in Psen2 
display a gain of function mechanism. As expected, double Psen1/Psen2 KO mice show a 
phenotype closely resembling that induced by Notch1 KO, with premature embryonic 
lethality and neural tube and somite alterations (Donoviel et al., 1999). Since double PSs 
KO is lethal, conditional double Psen1/Psen2 KO mice have been generated. The resulting 
phenotype is more severe than single Psen1 conditional KO: mice show forebrain 
degeneration, neuronal atrophy, tau hyperphosphorylation and increased apoptosis (Feng et 
al., 2004).  Neuronal degeneration starts at 2 months of age, age at which mild impairment 
in hippocampal memory and synaptic plasticity were observed in another double 
conditional KO model (Saura et al., 2004). 
Transgenic mice expressing FAD human mutated presenilins have been developed as well. 
Surprisingly, they do not mimic AD pathogenesis: they lack the characteristic 
neuropathology found in AD, and Aβ plaques and neurofibrillary tangles are absent. 
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However, these mice show some alterations, ranging from age-related neurodegeneration, 
vascular pathology altered spine density and morphology, to abnormal tau phosphorylation 
(van Tijn et al., 2011).  
 
1.10.2 Zebrafish models 
Besides mice, additional animal models have been developed to study presenilin functions, 
including C. elegans (Baumeister et al., 1997), Drosophila (Guo et al., 1999) and zebrafish. 
Among them, zebrafish represents the most interesting model for in vivo studies: it has 
orthologues of presenilin genes; it displays many advantages (see section 1.6) and it is a 
vertebrate, being more similar to rodents and humans than invertebrate models. 
Zebrafish PSs share several characteristics with the human one: they are both membrane 
spanning proteins; they conserve the catalytic residues responsible for γ-secretase activity 
and they are both involved in Notch signaling (Newman et al., 2011, 2014). psen1 mRNA 
is expressed maternally and ubiquitously during development; as the human protein, Psen1 
in zebrafish is endoproteolitically cleaved to generate CTF and NTF fragments. psen1 KD 
results in a phenotype that strongly resembles Notch depletion (Fig. 1-10 B): somite 
defects, increased neurogenesis, altered expression pattern of Notch target genes, reduced 
pigmentation, short tail, smaller head and defective brain development (Nornes et al., 
2008).  
As psen1, psen2 mRNA is maternally inherited, but it is translated only from 6 hours 
onwards (Groth et al., 2002). Reducing psen2 expression by a translation-blocking 
morpholino results in a phenotype similar to psen1 KD (Fig. 1-10 C): reduced melanin 
pigmentation, altered gene expression, and decreased Notch signaling (Nornes et al., 
2009). However, only psen2 KD increases the number of dorsal longitudinal ascending 
interneurons, suggesting the existence of non-redundant roles for both presenilins in 
zebrafish. 
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Figure 1-10. Presenilins knockdown in zebrafish. Lateral view of 48 hpf zebrafish embryos injected with control, 
MOPS1Tln and MoPS2Tln morpholinos. A) Embryos injected with control morpholino (Cont) do not show any 
morphological alteration. psen1 (B) psen2 (C) knock-down or the knock-down of both genes (D) result in reduced 
pigmentation and body size and expanded midbrain and hindbrain ventricular spaces (arrow heads in C). From (Nornes et 
al., 2009). 
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2 Material and methods 
2.1 Zebrafish keeping and maintenance 
All experiments were performed using wild-type (Giotto) (Facchin et al., 2009) and AB 
strains and transgenic fish (Tg(EPV.Tp1-Mmu.Hbb:nlsmCherry)ia7, [Et(1.5hsp70l:Gal4-
VP16)s1102t;Tg(UAS-E1b:Kaede)s1999t]. To restrict Gal4 expression to RB sensory 
neurons, the already described s1102t:GAL4/UAS:Kaede [Et(1.5hsp70l:Gal4-
VP16)s1102t;Tg(UAS-E1b:Kaede)s1999t] zebrafish transgenic line, which constitutively 
express cytosolic Kaede in RB neurons, was backcrossed with WT fish. Fish positive only 
for the Gal4 genotype (s1102t:Gal4) were raised to adulthood and used for further 
experiments. To genotype Gal4 positive fish, the primers Forward 
GTCTCAGCCTCACTTTGAGC and Reverse TGTTAGAGGCATATCAGTCTCCAC 
were used. Embryos were kept in fish water (25 mM NaH2PO4, 25 mM Na2HPO4, 75 g 
Istant Ocean for 5 liter) at 28,5°C, raised and, once adult, mated as previously described 
(Kimmel et al., 1995; Westerfield, 1989). For injection experiments, plasmids and mRNAs 
were diluted in Danieau solution (58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO4, 0.6 mM 
Ca(NO3)2, 5 mM HEPES pH 7.6) and 0.5% phenol red. Embryos that had to be screened 
for fluorescence and analysed at stages later than 24 hpf were treated from 24 hpf to the 
time of analysis with the tyrosinase inhibitor 1-phenyl-2-thiourea (PTU, Sigma).  
2.2 Generation of expression plasmids 
In order to target Kaede to mitochondria, a mitochondrial targeting sequence (MTS, from 
subunit VIII of human cytochrome C oxidase) was introduced at the N-terminus of Kaede 
by PCR, amplifying Kaede from pME-KAEDE plasmid (kindly donated by Francesco 
Argenton, Department of Biology, University of Padua) with the primers Forward: 
ATTATACCGGATCCATGGTGAGTCTGATTAAACCAGAAATGA and Reverse: 
ATTAGCGGCCGCTTACTTGACGTTGTCCGGCAAT. The PCR product was first 
subcloned into pCR®-BluntIITOPO® and then in BamHI/NotI sites of pEYFP-mito vector 
(Clontech). The resulting pMT-Kaede plasmid was cut with NotI e NheI and the fragment 
containing MT-Kaede was cloned into NotI and SpeI sites of pME-MCS, in order to obtain 
a middle entry vector (pME-MT-Kaede) to be used with the Gateway® Cloning 
Technology (Life Technologies). The final expression vector was obtained by recombining 
the entry vectors p5E-UAS, pE-poly-A and pME-MT-Kaede with the destination vector 
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pDestTol2pCG2 (Tol-2 kit).  1-2 nl of 30 ng/ul of pTol2-UAS-MT-Kaede (referred to 
UAS:MT-Kaede hereafter) were then injected into 1–2 cell stage embryos to obtain 
transient and mosaic expression of the transgene.  
2.3 PS2 genetic manipulation 
2.3.1 PS2 overexpression 
To overexpress human PS2 in zebrafish embryos we used both mRNA and DNA injection 
based approaches. To obtain PS2 mRNA, the fragment encoding for human PS2 (wt or 
T122R) was amplified from pcDNA3-PS2 with primers Forward: 
CACCATGCTCACATTCATGGCCTCTGAC and Reverse: 
AGATCTAGCCATAGAGCCCACCGCAT, then subcloned into pCR®-BluntIITOPO®. 
mRNA was generated by BglII linearized templates using the Ambion mMESSAGE 
mMACHINE® kit (Life Technologies). For transport assay, embryos were injected with 1-
2 nl of 30 ng/ul PS2 mRNA and pTol2-UAS-MT-Kaede vector.  
To selectively overexpress human PS2 in RB cells, the fragment encoding for human PS2 
was cloned into BamHI/XbaI sites of pME-MCS to obtain pME-PS2. This latter was then 
recombined with p5E-UAS, pE-poly-A and pDestTol2pCG2 (Tol-2 kit) to obtain the pTol-
2-UAS-PS2. The same strategy was used to obtain the pTol2-UAS-cpV-PS2 construct, 
encoding for the fluorescent protein circularly permutated Venus (cpV) fused to the N-
terminus of human PS2. 
2.3.2 psen2 knockdown 
Presenilins knockdown was performed using the already described MoPS1Tln and 
MoPS2Tln mopholinos (Nornes et al., 2009). Morpholinos were dissolved in distilled 
water at a final concentration of 1 mM and injected into fertilized eggs at a 0,3 mM 
concentration. For rescue experiments, 1-2 nl of 30 ng/ul mRNA transcribed from the 
TOPO-PS2-construct was injected into 1–2 cell stage embryos. 
2.4 mcu knockdown 
mcu knockdown was performed by using a translation-blocking morpholino kindly donated 
by Giorgia Palafacchina (Department of Biomedical Sciences, University of Padua and 
CNR Neuroscience Institute). The oligo recognizes a sequence encompassing the 
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translation starting sites of mcu mRNA, inhibiting its translation. Morpholino was 
dissolved at a final concentration of 1 mM and injected in fertilized eggs at a 0,18 mM 
concentration. For each experiment, before imaging, a pool of embryos was used for 
protein extraction and western blotting, in order to confirm the efficiency of the KD.     
2.5 Nocodazole treatment  
At 1 day post-fertilization, embryos were screened for MT-Kaede expression and then 
transferred into a 12 well plate. Nocodazole (200-300 nM, Sigma) was dissolved in fish 
water containing 0,1% DMSO (Sigma) and 1X PTU. Control embryos were incubated in 
fish water containing 0,1% DMSO and 1X PTU. Embryos were maintained in these 
solutions for the following 24 hours before imaging at 48 hpf. 
2.6 Imaging  
2.6.1 In vivo imaging 
At 1 day post fertilization, embryos were screened for fluorescence and treated with PTU if 
necessary. To prepare fish for imaging, embryos were manually dechorionated, 
anesthetized using tricaine (Sigma) and mounted in low melting agarose (1,2-1,3%, 
Euroclone) in small Petri dishes (Ted Pella, INC). During imaging, embryos were kept 
anesthetized by adding tricaine-containing fish water directly into Petri dishes. For 
nocodazole treatment, fish were anesthetized, mounted and imaged in a solution containing 
nocodazole (200-300nM, Sigma) and 0,1% DMSO. Control solution was added with 0,1% 
DMSO and embryos staged as nocodazole treated ones.  
Mitochondrial transport was imaged at room temperature (RT) using a Leica TSC SP5 
confocal microscope, equipped with Ar/ArKr 488 nm (GFP) and  He/Ne 543 nm (RFP) 
laser lines and a 405 nm cw 50 mW line, using either a 60X or a 100X oil-immersion 
objective. Mitochondrial transport was preferentially tracked in the stem axon, the portion 
of axon from the cell body to the first peripheral branch point, and monitored by imaging 
axons for 2 minutes (frame interval: 2 to 5 s). To image mitochondrial distribution in 
nocodazole treated embryos, mitochondria were imaged in the fin fold, were axons 
branches to innervate the tail. Z-stacks maximum projections were used to compare 
mitochondrial distribution among treated fish and controls.  
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To photoconvert Kaede, a region of interest (ROI) was set in the cell body of a RB neuron 
to prevent UV light from photoconverting neighbour cells. Photoconversion was 
performed by illuminating the sample with a 405 laser from 30 to 60 seconds. After 
fluorescence shift occurred, mitochondria were tracked in the red channel.  
2.6.2 Image analysis  
Images were processed using the open-source Fiji software (http://fiji.sc/Fiji). 
Mitochondrial transport was monitored and quantified by generating kymographs. 
Kymographs represent the movement of a particle over time using plots: vertical lines 
represent stationary mitochondria, whereas slanting lines show moving mitochondria, 
whose directionality and speed can be calculated taking into account the slope of the line. 
Kymographs were generated using the reslice tool. Briefly a maximum projection of all z-
stack slices (for each time-lapse movie) was obtained using the z-stack option; the 
projected movies were straighten using the straighten plugin, in order to accurately 
measure distances. Straightened, cropped movies were resliced to obtain kymographs. 
Mitochondrial average speeds were calculated by measuring the distance mitochondria 
moved from t0 to the end of the movie. Mitochondrial flux was measured as the number of 
moving mitochondria over the number of total mitochondria in the region imaged. 
Occasionally, the cell body from which the axon had sprouted was easily identified, 
allowing anterograde and retrograde movements to be discerned by taking into account the 
slope of the line from which average speed is calculated. A mitochondrion was considered 
as moving if its average speed was ≥0,08 µm/s. 
To determine mitochondrial density, the number of mitochondria in the ROI was divided 
over the length of the ROI in µm. Briefly, maximum projections of time-lapse movies were 
straightened and resliced; the resulting kymographs were used to count the number of 
mitochondria and measure neurite length. 
Mitochondrial morphology was evaluated using the ImageJ macro “Morphometry”, 
previously described by Cribbs and Strack (Cribbs and Strack, 2009). This macro measures 
mitochondrial morphology by using two parameters: aspect ratio (the major axis divided 
by minor axis) and form factor, which takes into account perimeter and area and is able to 
capture complex mitochondrial shapes.  
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2.7 Western blot 
Dechorionated embryos were deyolked (55 mM NaCl, 1,8 mM KCl, 1,25 mM NaHCO3) 
and stored at -80 °C before lysis. Protein extraction was performed by adding RIPA with 
protease inhibitors (50 mM Tris pH 7,5, 150 mM NaCl, 1% Triton, 0,1% SDS, 1% sodium 
deoxycolate, 1 nM DTT, phospho-stop (Roche) and 1 mM PMSF) to embryos and 
incubating on ice for at least 30 minutes. Proteins were quantified using the BCA protein 
assay (Pierce Biotechnology, Inc.) and transferred to nitrocellulose membranes using a wet 
electrotransfer system. Membranes were blocked with 5% milk in phosphate-buffered 
saline containing 0.1% Tween 20 (PBT) for 1 hour at RT and incubated with primary 
antibodies (anti-MCU Sigma HPA016480, 1:1000) overnight at 4°C. Membranes were 
then washed 15 min in PBT for three times and incubated with secondary antibody (anti-
rabbit Biorad 170-6515, 1:10000) diluted in PBT. Proteins were normalized to Tom20 
levels following the conditions previously described, except for incubation time that were 
of 1 hour for both primary and secondary antibody (anti-Tom20 Santa Cruz FL-145, 
1:10000; anti-rabbit Biorad 170-6515 1:10000). After incubation with secondary 
antibodies membranes were washed three times in PBT and visualized with LiteAblot® 
EXTEND Long Lasting Chemiluminescent Substrate (Euroclone) using a ChemiDocTM 
XRS System (Bio-Rad). 
2.8 Whole-mount Immunoistochemistry 
When necessary, embryos were first screened for fluorescence at 24 hpf, then 
dechorionated and fixed in PFA 4% for 2 hours at RT or overnight at 4 °C. After fixation, 
embryos where washed 5 min in PBT for three times, permeabilized in absolute methanol 
at -20 °C (for at least 1 night) and then incubated in cold acetone for 7 min at -20 °C. They 
were then rehydrated with decreasing concentration of methanol in PBS, washed at RT 
with PBTX (1% Triton-X 100 in PBS) and then incubated with primary antibody (anti-PS2 
Santa Cruz C-2, 1:35; anti-Tom20 Santa Cruz FL-145, 1:100) diluted in PBTX 2 days at 
4°C. After incubation, embryos were washed as previously (3 times for 10 min and 3 times 
for 30 min) and incubated with secondary antibody (anti-rabbit Invitrogen T-2769, 1:500; 
anti-goat Invitrogen A-11057, 1:300) diluted in PBTX overnight at 4°C. Samples were 
then washed again with PBTX, embedded in 1,2-1,3% low-melting agarose (Euroclone), 
mounted on microscope slides and analyzed with a Leica TSC SP5 microscope. Images 
were processed using Fiji software (http://fiji.sc/Fiji). 
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2.9 Birefringence assay 
Birefringence assay was performed as previously described (Zulian et al., 2014) using a 
Leica M165FC stereomicroscope. Briefly, 48 hpf embryos were anesthetized, placed on a 
glass slide and then analysed using two polarizing filters: the first producing polarized light 
that illuminates the embryos; the second detecting refracted light coming from muscle 
fibers. 
2.10 Touch evoked escape response assay 
To test motor activity, the touch evoked escape response assay was performed as 
previously described (Zulian et al., 2014). Briefly, at 2 dpf, embryos were positioned in the 
middle of a Petri dish and gently touched with a tip. Escape response was observed by light 
microscopy. Embryos were subdivided into 4 groups, with scores from 0 to 3: 0= embryos 
are paralized and do not respond to touch stimuli; 1= embryos respond only with coiling 
events, without swimming; 2= embryos display mild motor impairments; 3= embryos 
display a normal touch evoked escape response, rapidly escaping after providing touch 
stimuli.   
2.11 Statistics 
All statistical analysis were performed using GraphPad Prism version 5.00 for Windows, 
GraphPad Software, San Diego California USA, www.graphpad.com. Data were tested for 
normality using the D’Agostino-Pearson test: if normal distribution was confirmed, t-test 
was used to compare the samples. Otherwise, Mann-Whitney test was used to compare 
datasets that do not followed a normal distribution. Data are presented as mean with SEM. 
p-values ≤ 0.05 were considered significant: * = p ≤ 0.05; ** = p ≤ 0.01; *** = p ≤ 0.001; 
**** = p≤ 0.0001). 
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3 Results 
3.1 Visualization of mitochondria in zebrafish RB sensory 
neurons 
To track their axonal transport in a live, vertebrate system, mitochondria were genetically 
labelled by the expression of Kaede, a fluorescent protein isolated from the stony coral 
Trachyphyllia geoffroyi, that can be photoconverted from green (508/518 nm exct./emiss. 
maxima) to red (572/580 nm exct./emiss. maxima) by UV light (Ando et al., 2002). Kaede 
was targeted to mitochondria through the mitochondrial targeting sequence of the human 
COX VIII (cytocrome c oxidase subunit VIII) (Fig. 2-1 A), then cloned downstream of the 
Gal4-binding UAS sequence to generate the construct UAS:MT-Kaede (Fig. 2-1 B). This 
plasmid was injected into fertilized eggs at the one cell stage and embryos were assayed 
for mitochondrial axonal transport from 1 to 3 days post fertilization (dpf). Plasmid 
expression was restricted to Rohon-Beard (RB) sensory neurons by injecting it in 
s1102t:Gal4 embryos, which selectively expresses the Gal4 transcription factor in RB 
cells.  
Injection of the UAS:MT-Kaede construct resulted in a mosaic expression of the transgene 
(Fig 2-1 C-E), often allowing mitochondrial axonal transport to be imaged in single 
neurons (Fig. 2-1 E). Transgene expression persisted during the first days of development, 
and fluorescence intensities did not drop even on the last stage analyzed (3 dpf). At each 
developmental phase (from 1 to 3 dpf), mitochondria were present in the cell body of RB 
neurons, where they formed a highly compact network, whereas they had a more spaced 
distribution in the axon, with single mitochondria differing in size and speed (Fig. 2-1 D, 
E). Moreover, we did not observe evident alterations due to toxic effects following 
transgene expression, both in the overall morphology of embryos and in single labeled 
neurons, as we noted, on the contrary, by using other constructs that label mitochondria.  
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Figure 2-1. In vivo labeling of mitochondria in zebrafish RB sensory neurons. A-A’’) To confirm the mitochondrial 
targeting of the Kaede protein (green, A), 1 dpf embryos injected with pMT-Kaede were immunostained with anti-
Tom20 antibody (red, A’). A’’ represents the colocalized fluorescence. Scale Bar: 10 µm. B) Schematic representation of 
the transgene included in the UAS:MT-Kaede construct used to express Kaede in RB cells of s1102t:Gal4 embryos. Blue 
boxes represent Tol2 sequences. C) Expression at 1 dpf of the UAS:MT-Kaede plasmid in RB neurons of a s1102t:Gal4 
fish. Scale bar: 150 µm. D) Mitochondrial distribution in both peripheral axons that innervate the skin (arrowhead) and in 
central axons extending rostrally (right) and caudally (left, arrow) of RB neurons. Scale bar: 50 µm. E) A single RB 
neuron labeled with  the UAS:MT-Kaede construct in a live 1 dpf embryo. Scale bar: 10 µm.  
 
3.2 Imaging mitochondrial axonal transport in living zebrafish 
Mitochondrial axonal transport was monitored by imaging RB neurons for 2 minutes using 
a confocal microscope and transport parameters were quantified through the analysis of 
kymographs (Fig. 2-2 A, B). Kymographs are plots representing the spatial location of a 
particle over time: vertical lines represent stationary mitochondria, whereas slanting lines 
show moving mitochondria (with the slope of the line indicating the directionality of 
movements).  
To validate Kaede photoconversion in vivo, the cell body of RB neurons was illuminated 
with UV light for up to 60 seconds: such an exposure was sufficient to photoconvert Kaede 
from green to red emission (Fig. 2-2 C, D). Just after the fluorescence shift occurred, 
photoconverted, red mitochondria were observed moving within the axon from the cell 
body towards the periphery, as expected (Fig. 2-2 D’).  
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Figure 2-2 Mitochondrial tracking in RB neurons. A) A single axon was imaged for 2 minutes at a frequency of 0,33 
Hz. Each panel in A represents a single frame with intervals of 24 seconds. Arrowheads point to moving mitochondria 
(blue, anterograde; red, retrograde). B) Kymographs plotting mitochondrial movements showed in A over time. Scale 
bar: 10 µm. C) Kaede photoconversion. The dashed region was illuminated with UV light from 30 to 60 seconds: the 
Kaede there localized shifted emission from green to red (D). C’, D’) Kymographs show photoconverted mitochondria 
(red) moving anterogradely from the cell body towards cell periphery.  Scale bar: 10 µm.  
 
3.3 Mitochondrial axonal transport properties in RB neurons 
To characterize mitochondrial axonal transport properties in RB neurons, mitochondria 
were imaged in zebrafish embryos at 1, 2 and 3 days post fertilization (dpf). Mitochondria 
were preferentially tracked in the stem axon of RB cells, the portion of the axon from the 
cell body to the first peripheral branch point. Mitochondria displayed different complex 
transport patterns: they moved bidirectionally in the axon, sometimes changing their 
direction, moving toward the axon terminal and suddenly reversing their orientation, and 
vice versa. Mitochondria were also observed to fluctuate, being stationary before moving 
in a specific direction; fusion and fission events were also frequently reported during these 
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Figure 2-3. Mitochondrial transport dynamics during development. A) Mitochondrial flux in the stem axon at 1 dpf. 
Mitochondrial transport was strongly biased towards anterograde transport. Values are referred to mitochondria moving 
in each direction over the total number of mitochondria in the axon. n of cells:  antero = 31; retro = 31. B) Mitochondrial 
average speed measured for mitochondria moving in the anterograde and retrograde direction. n of mitochondria: antero 
= 90; retro = 76. C) Mitochondrial fluxes during development. n of cells: 1 dpf = 43; 2 dpf = 121; 3 dpf = 37. D) 
Mitochondrial average speed, including stationary periods, measured at different developmental stages. Values on the y-
axis were re-scaled in order to accentuate differences. n of mitochondria: 1 dpf = 320; 2 dpf > 500; 3 dfp = 230. E) 
Mitochondrial density in axon tracts during development. n of axons: 1 dpf = 51; 2 dpf = 43; 3 dpf = 36.  * = p ≤ 0.05; ** 
= p ≤ 0.01; *** = p ≤ 0.001. 
 
runs. Sometimes the cell body from which the analyzed axon had sprouted was clearly 
identified: in these cases, anterograde and retrograde movements could be easily discerned.  
The main parameters that characterize mitochondrial axonal transport were measured: 
directionality of movements (anterograde vs retrograde), mitochondrial flux (expressed as 
the percentage of mobile mitochondria over their total number in the axon), average speed 
and mitochondrial density (number of mitochondria/axon length in µm).  
As reported in Fig. 2-3, more mitochondria moved in the anterograde than retrograde 
direction (antero: 0.25 % ± 0.02 vs  retro: 0.11 %  ± 0.01), leading to a net translocation of 
mitochondria from the soma to synapses (Fig. 2-3 A). Mitochondria moving retrogradely 
did not display a different average speed compared to anterogradely-moving ones (Fig. 2-3 
B). In all imaged axons, the majority of mitochondria were stationary, being mitochondrial 
flux average smaller than 35 %. Mitochondrial flux did not change in the first 2 days (1 
dpf: 32.28 % ± 1.77 vs 2 dpf: 30.95 % ± 1.13), but drastically decreased at 3 dpf (20.02 % 
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± 1.80; Fig. 2-3 C). On the contrary, mitochondrial average speed slightly increased during 
development (1 dpf: 0.47 µm/s ± 0.01; 2 dpf: 0.52 µm/s ± 0.01; 3 dpf: 0.54 µm/s ± 0.01; 
Fig. 2-3 D), probably to compensate the decreased number of mobile mitochondria. 
Although mitochondrial flux is reduced at 3 dpf, mitochondrial density was observed to 
slightly increase (1 dpf: 0.26 mito/µm ± 0.01; 2 dpf: 0.31 mito/µm ± 0.01; 3dpf: 0.30 
mito/µm ± 0.01, Fig. 2-3 E).  
 
3.4 Nocodazole treatment disrupts mitochondrial axonal 
transport 
Mitochondria are transported in the axon via binding to kinesin and dynein motor proteins, 
which in turn bind to microtubule tracks. To test whether changes in mitochondrial 
transport could be detected in our system, fish were treated with nocodazole, an inhibitor 
of microtubule polymerization. As a consequence, a strong reduction in mitochondrial 
density within RB axonal peripheral branches that innervate the tail of the embryo was 
observed. In control fish (treated only with DMSO), mitochondria were distributed through 
all the axon and peripheral branches that innervate the fin fold (Fig. 2-4 A). Nocodazole 
treatment, instead, reduced mitochondrial density in peripheral arbors of  RB axons (Fig. 2-
4 B).  
We then tracked mitochondrial fluxes in DMSO- and nocodazole-treated fish. As expected, 
mitochondrial transport parameters were totally altered by drug treatment. Mitochondrial 
flux as well as average speed were strongly decreased, reflecting a general and broad 
impairment of microtubule tracks (mitochondrial flux: control 24.80 % ± 2.36 vs 
nocodazole 10.15 % ± 2.35; average speed: control 0.65 ± 0.03 µm/s vs nocodazole 0.48 ± 
0.07 µm/s; Fig 2-4 C-E). These data demonstrate that our approach is able to detect 
changes in mitochondrial transport properties, thus representing an appropriate system to 
investigate the involvement of possible candidate proteins in the regulation of 
mitochondrial axonal transport.   
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Figure 2-4. Mitochondrial distribution and transport alterations upon nocodazole treatment. 2 dpf fish were treated 
with nocodazole (200-300 µM) for 24 hours, then imaged to analyze mitochondrial distribution and axonal transport 
properties. A) Mitochondrial distribution in the fin fold of DMSO-treated control embryos. Scale bar: 50 µm. Antero is 
on the top-left, dorsal on the right. B) Peripheral RB axonal arbors of nocodazole-treated fish displayed a strong 
reduction of mitochondrial density. The embryo is oriented as in A. C) Representative kymographs of DMSO and 
nocodazole-treated fish. Scale bar: 10 µm. D, E) Mitochondrial flux (D, n of cells: ctrl = 20; nocodazole = 15) and  
mitochondrial average speed (E, n of mitochondria : ctrl = 154, nocodazole = 44) upon nocodazole treatment. ** = p ≤ 
0.01; *** = p ≤ 0.001. 
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3.5 psen2 Knockdown 
To knockdown psen2, we used the already described MoPS2Tln (referred to as MoPS2 
hereafter) (Nornes et al., 2009). This antisense oligonucleotide binds to a region of the 5’ 
untranslated region of psen2 zebrafish mRNA, blocking its translation. Morpholino 
injection led to a clear phenotype easily distinguishable at 2 dpf (Fig 2-5 A, B): reduction 
in trunk pigmentation and decrease in head and eye size. These phenotypic alterations are 
closely linked to an aberrant Notch signaling cascade: since Psen2 is involved in Notch 
processing, being the catalytic core of the γ-secretase complex, psen2 knockdown (KD) 
reduces NICD levels, affecting neural crest formation in the trunk of zebrafish embryos. 
Notch is also involved in the proliferation of eye cells (Baonza and Freeman, 2005): 
reduction of NICD levels could explain the reduction of eye size observed in psen2 
morphants. The efficacy of the MoPS2 morpholino in blocking Notch signaling was 
evaluated by using the Tg(EPV.Tp1-Mmu.Hbb:nlsmCherry)ia7 transgenic fish line, which 
expresses nuclear mCherry (NLS-mCherry) under the control of Notch-responsive 
elements. MoPS2 injection strongly reduced mCherry levels, demonstrating an inhibition 
of the Notch signaling pathway due to a decreased Psen2 expression (Fig. 2-5 C-E).  
Since Notch signaling is involved in somitogenesis and muscle development (Pascoal et 
al., 2013), muscle structure was analyzed by birefringence. This technique has proved to be 
a powerful tool to measure muscle alterations in zebrafish embryos (Berger et al., 2012). 
By using polarized light, zebrafish muscles can be detected as a bright area in a dark 
background. This light effect (birefringence) is due to the diffraction of polarized light 
through the array of muscle sarcomeres. Muscle fibers of control fish appeared as bright 
structures along the trunk of the embryo (Fig 2-5 G, G’). By contrast, psen2 morphants 
showed a high muscle damage detected by a reduction in birefringence (Fig. 2-5 H, H’).  
Finally, impairments in the touch evoked escape response assay were observed in psen2 
morphants (Fig. 2-5 F). This response consists on an escape behavior that fish exhibit from 
27 hpf when challenged with tactile stimuli. This stimulation activates a circuit that results 
in the contraction of trunk and tail muscles, propelling the embryo away from the stimulus.  
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Figure 2-5. psen2 knockdown effects. Images are referred to 2 dpf embryos. Left panels deals with control embryos 
(Ctrl-Mo: control morpholino), right panels to embryos injected with MoPS2 morpholino. A, B) psen2 KD (B) reduced 
trunk pigmentation and head and eyes size as compared to controls (A). A’, B’) Magnification of the same images as in A 
and B. C, D) MoPS2 injection (D) strongly reduced Notch signaling as revealed by the NLS-mCherry fluorescence. Bar: 
100 µm. E) Quantification of mCherry levels. Integrated (Int.) density is a measure of pixel intensity. n of embryos: ctrl-
Mo = 21; MoPS2 = 21. *** = p ≤ 0.001. F) Alterations in the touch response assay upon psen2 KD. Legend: 0: no 
response, 1: coiling events, 3: mild motor impairments, 4: normal swimming. p ≤ 0.0001. G, H) Birefringence images 
show the highly ordinated sarcomeric structure of muscle fibers in controls (G-G’) and psen2 morphants (H’-H’). 
Magnification in G’-H’ are referred to the dashed regions indicated in G-H. n of embryos: Ctrl = 18; MoPS2 = 25. *** = 
p ≤ 0.001. 
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This circuit is restricted to the spinal cord and involve RB cells, CoPA (Commissural 
Primary Ascending) and motor neurons (Pietri et al., 2009). psen2 morphants displayed an 
altered touch response, including lack of response and minor motor impairments (Fig. 2-5 
F). This phenotype could be related either to an effect of psen2 KD on neuronal cells 
responsible for the touch response, e.g. RB, CoPA and motor neurons, or to a defect in 
muscles needed for the response to be manifested. Additional investigations are required to 
solve this point. 
3.6 Expression of human PS2 in live zebrafish embryos                   
To verify whether human PS2 function could be analyzed in zebrafish, human PS2 was 
expressed in zebrafish embryos by the injection of the UAS:cpV-PS2 plasmid, encoding 
for human wt PS2 fused to cpV (circularly permutated Venus, Fig. 2-6 A). Co-injcetion of 
this plasmid with a CMV-Gal4-VP16 led to mosaic expression of the transgene, allowing 
multiple cell types to be imaged in the same embryo. In mammalian cells, PS2 have been 
localized to several cellular compartments, including Golgi apparatus, plasma membrane 
and ER (Area-Gomez et al., 2009). To investigate the subcellular localization of the 
exogenous cpV-PS2 in zebrafish, immunoistochemistry against the protein was carried out 
and confirmed that the UAS:cpV-PS2 construct correctly encodes human PS2 localized at 
tubular structures that clearly resemble the ER (Fig. 2-6 B). To support this finding, we co-
injected the UAS:cpV-PS2 transgene with a Ds-Red2-ER construct, a common ER marker 
for living cells. As expected, PS2 co-localizes with the ER, demonstrating that in zebrafish 
human PS2 localization is conserved (Fig 2-6 C).  
In mammalian axons, the ER forms a network of irregular tubules and cisternae that 
closely interacts with mitochondria. This network is more or less contiguous with the 
highly interconnected cellular ER, located in the cell body (Villegas et al., 2014). In 
zebrafish neurons, the ER shares the same characteristics: by labeling the ER with the 
pcDNA3.1-AtlTM-GFP construct, encoding an ER-targeted GFP, clearly distinguishable 
neurons were occasionally found. As in vitro, ER forms a contiguous network in the cell 
body of zebrafish neurons that expands within the axon (Fig 2-6 D). To further 
characterize human PS2 subcellular distribution in zebrafish sensory neurons, the 
UAS:cpV-PS2 transgene expression was investigated in RB cells. PS2 distribution in 
sensory neurons resembles the expression pattern of ER in axons (Fig 2-6 E). 
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These data demonstrate that human PS2 is correctly expressed in zebrafish and maintains 
its specific subcellular localization.   
 
Figure 2-6. Human PS2 subcellular localization in zebrafish. A) Schematic representation of the transgene used to 
express and visualize human PS2. The cpV is fused to the N-terminus of human PS2. Blue boxes represent Tol2 
sequences. B-B’’) Whole-mount immunoistochemistry for human PS2. 1 dpf embryos injected with UAS:cpV-PS2 and 
CMV-GAL4-VP16 constructs (B) were fixed and immunostained using an antibody against PS2 (B’). Colocalization is 
shown in B’’. Scale bar: 10 µm. C) Z-stack projection of a cell co-expressing cpV-PS2 (C) and Ds-Red2-ER (C’) shows a 
perfect co-localization signal (yellow, C’’). Scale bar: 10 µm. D) ER distribution in zebrafish neurons. The image is 
referred to 1 dpf embryos expressing the pcDNA3.1-AtlTM-GFP transgene. Scale bar: 10 µm. E) Human PS2 distribution 
in a RB neuron strongly resembles the ER pattern. Scale bar: 10 µm. 
 
3.7 Effects of PS2 expression on mitochondrial axonal 
transport 
Ca2+ is one of the best-known regulators of mitochondrial axonal transport. Cytosolic 
(Macaskill et al., 2009; Wang and Schwarz, 2009) or mitochondrial matrix (Chang et al., 
2011) Ca2+ rises have been reported to arrest mitochondrial axonal transport. By increasing 
ER-mitochondria Ca2+ transfer and their interaction, we speculated that PS2 could 
potentially modify mitochondrial axonal transport. To test this hypothesis, the KD of 
zebrafish psen2 was carried out by MoPS2 morpholino and mitochondrial axonal transport 
was analyzed in RB cells at 2 dpf.  
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Figure 2-7. Presenilin 2 genetic manipulation affects mitochondrial axonal transport. A) psen2 KD reduced 
mitochondrial flux (n of cells: ctrl, MoPS2 > 50; rescue = 14), without affecting mitochondrial average speed (n of 
mitochondria >500). B) Representative kymographs showing mitochondrial flux in psen2 morphants. Scale bar: 10 µm.  
C) Human PS2-T122R expression increased mitochondrial flux (n of cells: ctrl = 44; PS2-T122R = 66; PS2 wt = 21), but 
not mitochondrial average speed (n of mitochondria: ctrl = 320; PS2-T122R = 454; PS2 wt = 170). D) Representative 
kymographs showing mitochondrial flux increase upon human PS2-T122R expression.  * = p ≤ 0.05; ** = p ≤ 0.01. 
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psen2 KD led to a decreased mitochondrial flux (Ctrl: 30.95 % ± 1.13 vs MoPS2: 25.71 % 
± 1.42) without however affecting mitochondrial average speed (Fig. 2-7 A, B). This 
alteration was reverted by rescue experiments, where mRNA encoding for human wt PS2 
was injected together to MoPS2, demonstrating a PS2 specific effect on this feature.  
PS2 overexpression by the injection of human PS2 mRNA led to different results: although 
wt PS2 was without effect, the FAD-linked PS2-T122R mutant increased mitochondrial 
flux at 1 dpf (Ctrl: 33.18 % ± 1.98 vs PS2-T122R: 40.48 % ± 2.21) but not mitochondrial 
average speed (Fig. 2-7 C, D).   
These data suggest a role of presenilin 2 in mitochondrial axonal transport, with mutant 
PS2 increasing it. 
 
3.8 psen1 knockdown  
As mammals, zebrafish possesses two presenilin genes, the previously described psen2 and 
its paralogue psen1. Like Psen2, Psen1 is a key component of the γ-secretase complex and 
it is involved in the Notch signaling pathway. Zebrafish psen1 knockdown results in a 
reduction of yolk extension thickness, of trunk pigmentation and of the overall fish size 
(Nornes et al., 2008). Although psen1 and psen2 share a high percentage of nucleotide 
sequence identity, they evolved specific independent functions. To check whether Psen1 
depletion could somehow affect mitochondrial axonal transport dynamics, as Psen2 
depletion does, we knocked-down psen1 using the available MoPS1Tln morpholino 
(referred as MoPS1 hereafter). psen1 KD reproduced a Notch-deficiency like phenotype, 
with size reduction of the eye and head, reduced pigmentation and body length (Fig. 2-8 
A). Mitochondrial axonal transport was characterized in psen1 morphants at 2 dpf. No 
difference was observed in morphant embryos in both mitochondrial flux and average 
speed, compared to controls (Fig. 2-8 B-D), suggesting that the alterations found upon 
Psen2 depletion, described above, are specific for Psen2 and not connected to the Notch 
signaling pathway. 
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Figure 2-8. psen1 knockdown effects. A) psen1 KD resulted in a reduction of eye, head and body size, as well as 
reduced trunk pigmentation. B) Representative kymographs of control and psen1 morphants. Scale bar: 10 µm. C, D) 
Mitochondrial fluxes (C, n of cells: ctrl = 121; MoPS1 = 37) and average mitochondrial speed  (D, n of mitochondria: ctrl 
= 1090; MoPS1 = 351) upon psen1 knockdown. 
 
3.9 mcu knockdown  
MCU has been recently identified as the channel subunit of the mitochondrial calcium 
uniporter complex, located at the inner mitochondrial membrane, which mediates Ca2+ 
entry into the mitochondrial matrix (Baughman et al., 2011; De Stefani et al., 2011). Being 
Ca2+ a key signal for the regulation of mitochondrial axonal transport (and indeed intra-
mitochondrial Ca2+ level has been suggested as a possible signal in the regulation of this 
feature) (Chang et al., 2011), the involvement of mitochondrial matrix Ca2+ levels in the 
regulation of the axonal transport of these organelles was investigated in vivo. 3 dpf 
embryos injected with a mcu translation-blocking morpholino, and relative controls, were 
investigated as above described. First of all, as reported in mice, no clear morphological 
alterations were observed in embryos depleted of the protein (Fig. 2-9 A). Surprisingly, 
mitochondrial transport was completely unaffected by mcu KD: neither mitochondrial flux 
nor mitochondrial average speed were altered by Mcu depletion (Fig 2-9 C-E). This 
suggest that signals other than mitochondrial matrix Ca2+ levels may regulate 
mitochondrial transport arrest. 
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Figure 2-9. mcu knockdown effects. A) Phenotype of control fish (Ctrl-Mo, injected with a control morpholino) and 
mcu morphants at 3 dpf. B) Western blot of lysates from 3 dpf embryos shows a strong reduction of Mcu levels in mcu 
morphants, compared to controls. The mitochondrial protein Tom20 is used as loading control. C,D) Representation of 
mitochondrial fluxes (C, n of cells = 37; Mo-MCU = 31) and average mitochondrial speed (D, n of mitochondria: ctrl = 
230; Mo-MCU = 187) upon mcu KD is shown. E) Representative kymographs of control and mcu morphants. Bar: 10 
µm.  
 
3.10 Mitochondrial morphology and density 
Mitochondrial dynamics play an important role in cell physiology and pathology. They are 
required to maintain a pool of functional mitochondria and sustain neuronal activity, but 
also to sequester dysfunctional mitochondria and target them to mitophagy. Although 
extensively studied in the cell body, these dynamics occur also in axons (Cagalinec et al., 
2013): mitochondrial dynamics and motility closely depend on each other, so one can 
speculate that alterations in mitochondrial motility could be due to defects in mitochondrial 
morphology. 
To check this possibility, mitochondrial morphology and densities were studied upon 
psen2 KD and human FAD-PS2-T122R expression (Fig 2-10). No difference was detected 
in both aspects: these data suggest that mitochondrial transport alterations described above 
are not due to neither an altered mitochondrial morphology nor to abnormal mitochondrial 
biogenesis. However further experiments are required to better understand whether 
fusion/fission dynamics are altered upon presenilin 2 manipulation.  
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Figure 2-10. Effects of psen2 knockdown and human FAD-linked PS2-T122R expression on mitochondrial 
morphology and density. Mitochondrial morphology upon psen2 KD (A) or human FAD-linked PS2-T122R expression 
(B) resulted unchanged. C) Mitochondrial density was not affected by PS2 genetic manipulation. n of cells for each 
condition = 20. Data are referred to 2 dpf embryos for MoPS2 and 1 dpf one for PS2-T122R. 
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4 Discussion 
Several evidence, collected over the past years, has revealed an altered Ca2+ homeostasis as 
a key event in AD pathogenesis. Presenilin 2 (PS2), a membrane spanning protein located 
in both plasma- and inner membranes, such as those of the Golgi apparatus and the ER 
(Kovacs et al., 1996), has proven to be able to modulate cellular Ca2+ handling at different 
levels. Mutations in the PSEN2 gene lead to the onset of a genetically inherited form of 
AD (FAD, Familial Alzheimer’s Disease). FAD-linked PS2 mutants have been shown to 
reduce the Ca2+ content of intracellular stores by inhibiting SERCA pump activity and 
increasing ER Ca2+ leak across IP3 Ca2+ channels (Brunello et al., 2009; Giacomello et al., 
2005; Kipanyula et al., 2012; Zampese et al., 2011a; Zatti et al., 2004, 2006). According to 
these data, and to the fact that FAD-PS2 mutants have been found to enhance IP3R single 
channel gating and sensitivity (Cheung et al., 2008, 2010), the “ER Ca2+ overload” 
hypothesis for AD has been recently changed in the “exaggerated ER Ca2+ release” 
mechanism linked to neuronal exocytotoxicity and cell death (Cheung et al., 2008, 2010). 
Recently, PS2 has been also shown to modulate ER-mitochondria physical interaction and 
their Ca2+ crosstalk (Zampese et al., 2011a). In particular, FAD-PS2 mutants have been 
reported to increase ER-mitochondria tethering and the number of Ca2+ hotspots generated 
at the OMM, thus resulting in increased mitochondrial Ca2+ uptake upon cell stimulation. 
As far as the pathology is concerned, a decreased ER Ca2+ content, as the one induced by 
FAD-PS2 mutant expression, is considered neuroprotective against Ca2+ dependent 
apoptotic stimuli. However, an increased contact between ER and mitochondria, and the 
consequent increased ER-mitochondria Ca2+ transfer, can lead, upon cell stimulation, to a 
higher possibility of a mitochondria Ca2+ overload-dependent toxicity. The increased ER-
mitochondria juxtaposition induced by FAD-PS2 could represent a mechanism to 
compensate for the reduced ER Ca2+ levels, thus ensuring proper fuel to the organelles for 
ATP production, and, at the same time, exerting a neuroprotective function against Ca2+ 
dependent apoptotic stimuli. Alternatively, the increased ER-mitochondria juxtaposition 
together with an exaggerated Ca2+ release from the ER, due to FAD-PS2 mutants, could 
lead more frequently to mitochondrial Ca2+ overload and eventually apoptosis.  
Many cellular processes are dependent on a proper Ca2+ signalling and could potentially be 
affected by the alterations in Ca2+ homeostasis previously described in AD. Among them, 
mitochondrial axonal transport alterations are an appealing explanation for the 
neurodegeneration described in AD: defects in mitochondrial axonal transport may lead to 
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an altered mitochondrial distribution inside neurons, affecting their function and survival. 
Indeed a modified mitochondrial distribution has been described in human AD fibroblasts 
and primary hippocampal neurons from APP-based AD transgenic mice (Wang et al., 
2008b, 2008c). Moreover, mitochondrial axonal transport defects are emerging as a 
common feature in many neurodegenerative diseases, including CMT, HSPs, ALS and AD 
(Millecamps and Julien, 2013).   
Mitochondria are key organelles for the cell, being implicated in many cellular processes 
ranging from ATP production to Ca2+ signaling and apoptosis. Among all cell types, 
neurons are particularly dependent on a proper mitochondrial function, to satisfy ATP and 
Ca2+ buffering requirements at synapses: mitochondria can provide both ATP and Ca2+ 
buffering capability, so it is not surprising that neurons have evolved a conserved 
mechanism to deliver mitochondria to proper sites, through anterograde and retrograde 
microtubule-based axonal transport (Sheng and Cai, 2012). In the past decades, many 
studies have provided new insights on the mechanisms that characterize this process, and 
many proteins have emerged as main players or regulators. There is a general consensus on 
the role played by Ca2+ in the regulation of mitochondrial axonal transport: increased Ca2+ 
levels lead to mitochondrial transport arrest (Macaskill et al., 2009; Wang and Schwarz, 
2009). However, different studies reached different conclusions, as whether cytosolic 
(Macaskill et al., 2009; Wang and Schwarz, 2009) or intra-mitochondrial Ca2+ levels 
(Chang et al., 2011) determine the transport arrest and whether this function is mediated by 
MIRO1 (Nguyen et al., 2014). Moreover, ER-mitochondria connections have been shown 
to be essential also for mitochondrial fission and the mechanism proposed for this function 
seems to be independent of mitofusin 2 (MFN2; one of the main ER-mitochondria 
molecular tethers; see below) but Ca2+-dependent, occurring at positions where ER 
contacts mitochondria, mediating organelle constriction before Drp1 recruitment 
(Friedman et al., 2011). Mitochondrial fission is an essential event involved in 
mitochondrial network shaping; indeed it is required to generate organelles that are small 
enough to be transported by molecular motors along the cytoskeleton. This is particularly 
important in large, differentiated cells, such as neurons, and during cell division. 
Moreover, mitochondrial fission is important for the release of cytochrome c from the 
mitochondrial inter-membrane space into the cytosol to trigger apoptosis, and it is thought 
to facilitate the removal of damaged organelles by autophagy (Westermann, 2010).  
Many systems have been developed in past years to further characterize mitochondrial 
axonal transport, and efforts have been made to transfer discoveries from cell cultures to 
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living animal models. However, this has proven to be challenging, due to the difficulty of 
finding non-invasive techniques that allow mitochondrial tracking. Zebrafish emerged as 
one of the most suitable models for such a purpose: in addition to its known general 
characteristics, embryo transparency really facilitates imaging and, being a vertebrate, its 
anatomy is closer to mammals than other widely used animal models. Indeed, zebrafish 
myelinated axons reproduce a more reliable environment than the Drosophila or 
Caenorhabditis ones. Furthermore, the availability of techniques to easily manipulate gene 
expression, combined with the availability of zebrafish lines, models of human diseases, 
makes it a very powerful tool. 
In order to investigate how FAD-PS2 could participate in the neurodegeneration typical of 
AD, we developed a system to track mitochondrial axonal transport in zebrafish RB 
neurons, a type of sensory neurons located dorsally in the spinal cord and characterized by 
very long axons. Being Ca2+ a crucial signal in the regulation of mitochondrial axonal 
transport, as well as of ER-mitochondria connections, we reasoned that, by making ER and 
mitochondria closer and by enhancing their Ca2+ transfer, mutated PS2 could potentially 
modify mitochondrial axonal transport. 
The tool we developed allows mitochondrial tracking to be performed in a non-invasive 
way: no surgery is required to access RB neurons and, of most interest, due to the bright 
fluorescence of the Kaede protein, imaging is fulfilled using low laser intensities. 
Phototoxicity represents a big problem in biological samples imaging: extended 
observation using high-energy light induces ROS production, leading to cellular damage 
and thus altering cell physiology (Dixit and Cyr, 2003). In addition, phototoxicity induces 
dramatic mitochondrial alterations, including disruption of cristae, swelling and 
fragmentation (Shea et al., 1990). The system we developed, by coupling short time-
exposure with low laser intensities, likely removes these problems. Indeed, no 
morphological alterations were observed in all the conditions tested, both for time-lapse 
imaging and confocal scanning. 
The mitochondrial axonal transport parameters here described closely resemble data 
obtained in zebrafish and recently published (O’Donnell et al., 2013; Plucińska et al., 
2012). The prevalence of stationary mitochondria compared to mobile organelles suggests 
that most mitochondria in zebrafish neurons are already localized at specific sites, where 
probably a high energy demand is required. Further investigations will clarify whether 
these sites could be synapses or other structures such as nodes of Ranvier, where 
mitochondria have been reported to accumulate (Chang et al., 2006; Zhang et al., 2010). 
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We observed mitochondrial axonal transport to be predominantly anterograde, leading to 
an evident translocation of mitochondria from the cell body to synapses, as previously 
reported (Pilling et al., 2006). Although this could be explained in our case as a 
consequence of axonal growth during development, its persistence in adult mice (Misgeld 
et al., 2007) suggests the possibility that dysfunctional mitochondria, instead of being 
retrogradely transported to the cell body for mitophagy, can be degraded distally in the 
axon. Indeed PINK1 and Parkin have been reported to provide mitophagic clearance of 
damaged mitochondria in axons (Ashrafi et al., 2014). Our system could potentially 
provide further evidence for such a process in vivo. Indeed, we managed to photoconvert 
Kaede in vivo, restricting such modification only to the soma and leaving axonal 
mitochondria unchanged. We also demonstrated that Kaede photoconversion is non-toxic, 
since red mitochondria were observed moving anterogradely very soon after 
photoconversion. This approach allows mitochondrial dynamics to be extensively studied 
in axons, by dividing the mitochondrial population in green, uncoverted mitochondria and 
their photoconverted, red counterpart, thus providing a tool to study fusion-fission rates 
and bidirectional movements. 
Our imaging conditions revealed dynamic changes in several mitochondrial transport 
parameters during zebrafish development, including a reduction in mitochondrial flux at 3 
dpf and slight increases in both mitochondrial density and average speed starting at 2 dpf. 
More interestingly, we were able to detect expected alterations in mitochondrial axonal 
transport upon nocodazole treatment, thus validating the sensitivity of our assay.  
In our hands, psen2 knockdown (KD) reproduced the described phenotype (Nornes et al., 
2009), including reduced eye and body size and trunk pigmentation. However, we did not 
observe the appearance of expanded mid- and hindbrain ventricular spaces. These latter 
phenotypic alterations are quite common using morpholino oligos and their lack in our 
experiments could be probably due to the decreased MoPS2Tln dose we used to 
knockdown psen2. However, the chosen dose was sufficient to strongly alter Notch 
signalling, as demonstrated by the phenotype described above. Moreover, we observed a 
general motor impairment in psen2 morphants: most fish displayed an altered touch-
evoked escape response. We detected muscular alterations in these fish, which are 
probably the cause for the motor impairment. However, aspects other than muscles, e.g. 
alterations in the reflex arc that involves sensory, inter- and motor neurons, could 
potentially explain this phenomenon. Since muscle alterations are a consequence of Notch 
signalling perturbations (Pascoal et al., 2013), the study of muscle structure in psen1 
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morphant embryos (which do not show any RB mitochondrial axonal transport alteration) 
will elucidate the cause of the motor impairments here described.  
In addition to these phenotypic changes, we observed a decreased mitochondrial flux in RB 
axons upon psen2, but not psen1, KD. The impairment was reverted by rescue 
experiments, in which mRNA encoding for wt human PS2 was co-injected with MoPS2, 
demonstrating a Psen2 specific effect. The opposite was seen upon human PS2-T122R 
expression, i.e. an increased mitochondrial flux, whereas this feature was unchanged upon 
human PS2 wt expression.  
These results suggest that mutations in PSEN2 could act through a “gain of function” 
mechanism, as far as mitochondrial axonal transport is concerned. However these data are 
very preliminary and further analysis are required to understand the causes of such 
changes. Although the relationship between mitochondrial axonal transport defects and 
axon degeneration is still a matter of debate, recent papers clearly demonstrated that 
mitochondrial distribution in axons has a protective role. Indeed axons devoid of 
mitochondria degenerate both in C. elegans and mice (Berthet et al., 2014; Rawson et al., 
2014), and mitochondrial transport restoration in these axons is sufficient to rescue 
neuronal function. The alterations here described upon presenilin 2 manipulation do not fit 
this scenario, since we did not observe changes in mitochondrial density. However, 
analysis at time points later than 2 dpf could reveal defects not manifested at the stages 
here analysed, but the rapid turnover of mRNA and morpholino makes this analysis 
unlikely. In addition, we can speculate that the defects we found could potentially alter 
mitochondrial distribution in the axon, depleting mitochondria from area with high energy 
demand, such as synapses, thus affecting their activity and contributing to neuronal 
dysfunction. Alternatively, the enhanced mitochondrial transport due to PS2-T122R 
expression could reflect a mitochondrial damage, that goes behind mitochondrial 
morphology: alterations in mitochondrial redox state, for instance, could potentially lead to 
an increased mitochondrial transport, in order to provide functional mitochondria or 
remove the dysfunctional ones from synapses.  
Since it is established that Ca2+ is a key regulator of mitochondrial axonal transport, we 
reasoned that Ca2+ dyshomeostasis linked to PS2 expression could explain the altered 
mitochondrial flux observed. However, the mechanism responsible for Ca2+-mediated 
transport arrest is not yet fully understood, and different groups provided conflicting 
explanations. MIRO1 is believed by most to be the cytosolic Ca2+ sensor that mediates 
mitochondrial axonal transport arrest (Macaskill et al., 2009; Saotome et al., 2008; Wang 
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and Schwarz, 2009). According to this view, we might expect that PS2 expression, by 
reducing ER Ca2+ stores, reduces cytosolic Ca2+ rises upon cell stimulation, keeping more 
mitochondria in motion because of the lack of an appropriate stop signal. This explanation 
is valid unless MIRO1 is located close to ER-mitochondria Ca2+ transfer sites: this is the 
case for the yeast orthologue of mammalian MIRO, Gem1, which colocalizes in specific 
foci whit the ERMES complex, the yeast ER-mitochondria linker, and for monkey MIRO, 
which localizes to ER-mitochondria contact sites (Kornmann et al., 2011). According to 
this, the increased number of Ca2+ hotspots generated at the OMM due to mutant PS2 
expression should arrest mitochondria more frequently. However, a recent work argued 
against MIRO1 as the main Ca2+ sensor for the regulation of mitochondrial axonal 
transport (Nguyen et al., 2014), making the previous hypothesis debatable. To further 
complicate this scenario, Ca2+ rises inside mitochondrial matrix have been reported to 
modulate mitochondrial axonal transport too (Chang et al., 2011). According to these data, 
the increased mitochondrial Ca2+ uptake linked to PS2-T122R expression should lead to 
mitochondrial transport arrest, just the opposing of what we have found. To better 
elucidate this aspect, we knocked-down mcu, the channel subunit of MCUC that mediates 
Ca2+ influx into mitochondrial matrix. No alterations were found in both mitochondrial 
flux and average speed, thus supporting the idea that signals other than mitochondrial 
matrix Ca2+ rises mediate mitochondrial transport arrest. 
Although our observations do not lead to a full comprehension of how FAD mutations in 
PSEN2 gene can affect mitochondrial transport and how this aspect contributes to the 
neurodegeneration and onset of the disease, they suggest that perturbations of 
mitochondrial axonal transport are a convergent feature of many neurodegenerative 
disorders. However the mechanisms that can lead to these defects can strongly differ 
among pathologies. Moreover our system proved to be a powerful tool to investigate 
mitochondrial axonal transport alterations under pathological conditions. Furthermore, 
other parameters related to mitochondrial properties have been easily measured with our 
approach, making us able to study mitochondria by different perspectives.  
Our knowledge of the proteins and pathways involved in mitochondrial axonal transport is 
not complete yet and many proteins are emerging as being involved in this process. 
Additional experiments are required to further validate our data, as the generation of psen2 
knockout fish (currently in progress), to study the effects of human FAD-PS2 in a 
background devoid of the fish wt protein. The study of the axonal transport of other 
cargoes (such as synaptic vesicles) could elucidate if the alterations described for 
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mitochondrial axonal transport are specific or due to a broad microtubule damage. 
Mitochondrial oxidative stress should also be investigated, since the redox state of 
mitochondria affects their axonal transport (O’Donnell et al., 2013). Moreover, the 
expression of the Ca2+ insensitive Miro1 mutant (Miro1E208K/E328K) could lead to new 
insights on the Ca2+ dependent regulation of mitochondrial axonal transport in vivo. 
Last but not least, possible partners could cooperate with PS2 to lead to the described 
defects. Mitofusin 2, for instance, has been reported to be necessary to increase ER-
mitochondria tethering by a PS2-dependent mechanism (unpublished results from our lab). 
Moreover, MFN2 has been shown to interact with components of the transport apparatus 
(composed by MIRO1/MIRO2 and by OIP106 and GRIF-1, the mammalian homologs of 
Milton) and Mfn2 KO neurons showed a decrease in mitochondrial motility which can not 
be rescued by MIRO2 overexpression. Thus, MFN2 and MIRO2 seem to act co-
operatively to regulate mitochondrial trafficking (Misko et al., 2010). Genetic 
manipulation of mfn2 together with psen2 should provide further understanding on this 
aspect. Thus, the possibility that MFN2 and PS2, all enriched in MAM (mitochondria 
associated membranes), could form a complex that regulate ER-mitochondria interactions 
is really fascinating, and could provide new insights on how mitochondrial axonal 
transport defects are related to pathologies as well as new molecular targets for drug 
screening.  
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chi è rimasto, siete come dei fratelli ed è bello sapere di lavorare con voi. 
Vorrei ringraziare la mia famiglia, le mie nonne, siete fantastiche, tutti i miei zii e i cugini 
più stretti, i miei fratelli che mi hanno sempre rotto le scatole, ma soprattutto i miei 
genitori, per i loro sacrifici nel permettermi di studiare lontano da casa e per avermi fatto 
crescere imparando ad arrangiarmi.  
Un grazie anche ai compagni di squadra dell’AR TEAM HARD SERVICE, senza di voi le 
domeniche non sarebbero le stesse. 
Un grazie alla persona che ho al mio fianco. Grazie per la tua eterna pazienza, ma ora non 
ribellarti troppo.  
Non per ultima, vorrei ringraziare la mia terra, poco conosciuta a molti ma di un valore 
inestimabile per me. Nonostante il mio precoce allontanamento, mi ha sempre dimostrato 
di ospitare un popolo “forte e gentile”, di cui sono fiero di far parte. Nella mia vita, 
ovunque io andrò, rimarrò sempre abruzzese.  
 
